CN108882873B - Biological information analysis device, system, and program - Google Patents
Biological information analysis device, system, and program Download PDFInfo
- Publication number
- CN108882873B CN108882873B CN201780022568.5A CN201780022568A CN108882873B CN 108882873 B CN108882873 B CN 108882873B CN 201780022568 A CN201780022568 A CN 201780022568A CN 108882873 B CN108882873 B CN 108882873B
- Authority
- CN
- China
- Prior art keywords
- blood pressure
- exercise
- pressure waveform
- index
- section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 59
- 230000036772 blood pressure Effects 0.000 claims abstract description 191
- 238000012545 processing Methods 0.000 claims abstract description 58
- 238000000605 extraction Methods 0.000 claims abstract description 37
- 230000004217 heart function Effects 0.000 claims abstract description 29
- 239000000284 extract Substances 0.000 claims abstract description 6
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 claims abstract description 3
- 230000033001 locomotion Effects 0.000 claims description 53
- 230000000694 effects Effects 0.000 claims description 42
- 230000035488 systolic blood pressure Effects 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 8
- 230000035487 diastolic blood pressure Effects 0.000 claims description 6
- 238000005259 measurement Methods 0.000 description 44
- 238000000034 method Methods 0.000 description 26
- 238000011156 evaluation Methods 0.000 description 22
- 230000008859 change Effects 0.000 description 20
- 238000010586 diagram Methods 0.000 description 14
- 238000011084 recovery Methods 0.000 description 10
- 238000009530 blood pressure measurement Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000002526 effect on cardiovascular system Effects 0.000 description 8
- 238000004891 communication Methods 0.000 description 7
- 210000002321 radial artery Anatomy 0.000 description 7
- 210000000707 wrist Anatomy 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000003416 augmentation Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 3
- 101100208381 Caenorhabditis elegans tth-1 gene Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000003205 diastolic effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000000449 premovement Effects 0.000 description 3
- 101000692225 Homo sapiens Selenocysteine insertion sequence-binding protein 2 Proteins 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 102100026077 Selenocysteine insertion sequence-binding protein 2 Human genes 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 210000001765 aortic valve Anatomy 0.000 description 2
- 208000008784 apnea Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 230000035485 pulse pressure Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 238000001966 tensiometry Methods 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/029—Measuring blood output from the heart, e.g. minute volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
- A61B5/02116—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
- A61B5/02125—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
- A61B5/02225—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers using the oscillometric method
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
- A61B5/02233—Occluders specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02438—Measuring pulse rate or heart rate with portable devices, e.g. worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
- A61B5/1118—Determining activity level
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/352—Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4818—Sleep apnoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/681—Wristwatch-type devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6824—Arm or wrist
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
- A61B5/721—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using a separate sensor to detect motion or using motion information derived from signals other than the physiological signal to be measured
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7278—Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/56—Devices for preventing snoring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
- A61M16/024—Control means therefor including calculation means, e.g. using a processor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F1/00—Details not covered by groups G06F3/00 - G06F13/00 and G06F21/00
- G06F1/16—Constructional details or arrangements
- G06F1/1613—Constructional details or arrangements for portable computers
- G06F1/163—Wearable computers, e.g. on a belt
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/029—Humidity sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02141—Details of apparatus construction, e.g. pump units or housings therefor, cuff pressurising systems, arrangements of fluid conduits or circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7221—Determining signal validity, reliability or quality
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
- A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0022—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the tactile sense, e.g. vibrations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0083—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus especially for waking up
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Signal Processing (AREA)
- Psychiatry (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Theoretical Computer Science (AREA)
- Primary Health Care (AREA)
- Dentistry (AREA)
- Computer Hardware Design (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nursing (AREA)
- Otolaryngology (AREA)
- Human Computer Interaction (AREA)
- Social Psychology (AREA)
- Emergency Medicine (AREA)
- General Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
Abstract
The biological information analysis device includes: an index extraction unit that acquires data of a blood pressure waveform in a pre-exercise section before exercise by a user and data of a blood pressure waveform in a post-exercise section after the exercise by the user from time-series data of blood pressure waveforms continuously measured by a sensor that is worn on a body of the user and can non-invasively measure a blood pressure waveform per heartbeat, and extracts an index indicating an influence of the exercise on a cardiac function of the user based on a feature of the blood pressure waveform in the pre-exercise section and a feature of the blood pressure waveform in the post-exercise section; and a processing unit that performs processing based on the extracted index.
Description
Technical Field
The present invention relates to a technique for acquiring useful information from a measured blood pressure waveform.
Background
A technique for measuring a change in internal pressure of a radial artery and recording the shape of a pressure pulse wave (blood pressure waveform) is known. Patent document 1 (japanese patent application laid-open No. 2008-61824) discloses measuring a blood pressure waveform by a tension method, and acquiring information such as an AI (Augmentation Index) value, a pulse wave period, a baseline fluctuation rate, a sharpness, and ET (Ejection Time) from the blood pressure waveform. Further, patent document 2 (japanese patent application laid-open No. 2005-532111) discloses that a blood pressure waveform is measured by a wristwatch type sphygmomanometer, and a mean arterial pressure, a mean systolic blood pressure, a mean diastolic blood pressure, a mean systolic blood pressure index, and a mean diastolic blood pressure index are calculated from the blood pressure waveform, and an alarm is output when these values deviate from a reference value.
Documents of the prior art
Patent document
Patent document 1: japanese laid-open patent publication No. 2008-61824
Patent document 2: japanese Kokai publication Hei-2005-532111
Disclosure of Invention
Problems to be solved by the invention
Exercise is known to be effective in improving blood pressure. However, if the movement does not continue for a certain period of time, the decompression effect cannot be obtained. Therefore, the user himself cannot imagine how much the exercise has an effect on himself, and there is a problem that motivation for doing exercise is not increased. In addition, excessive movement may instead become a physical burden. However, since it is not known how much the exercise being performed is loaded on the heart of the user or the like, there is a problem that it is impossible to determine what type of exercise is at risk to the user or what degree of exercise is appropriate.
The present inventors have made an effort to develop a blood pressure measuring device capable of accurately measuring a blood pressure waveform per heartbeat in a free movement. Through experiments by the subject in the development process, the present inventors found that various useful information can be extracted from blood pressure waveform data continuously measured in free motion.
It is therefore an object of the present invention to provide a new technique for evaluating the degree of influence of exercise on cardiac function based on data of blood pressure waveforms.
Technical scheme for solving problems
In order to achieve the above object, the present invention adopts the following configuration.
The biological information analysis device of the present invention is characterized by comprising: an index extraction unit that acquires data of a blood pressure waveform between pre-exercise periods before exercise by a user and data of a blood pressure waveform in a post-exercise period after the user performs the exercise from time-series data of blood pressure waveforms continuously measured by a sensor that is worn on a body of the user and can non-invasively measure a blood pressure waveform for each heartbeat, and extracts an index indicating an effect of the exercise on a cardiac function of the user based on a feature of the blood pressure waveform in the pre-exercise period and a feature of the blood pressure waveform in the post-exercise period; and a processing unit that performs processing based on the extracted index.
The blood pressure waveform is temporarily changed while the exercise is performed, and after the exercise is finished, the blood pressure waveform is gradually restored to the original state. The amount of change in the blood pressure waveform, the recovery time, the recovery speed, and the like at this time depend on the content of the exercise performed or the characteristics related to the cardiac function of the user. Therefore, by using the characteristics of the blood pressure waveform in the pre-exercise section and the characteristics of the blood pressure waveform in the post-exercise section as in the configuration of the present invention, the influence of exercise on the heart function of the user can be quantitatively evaluated.
Specifically, the index extraction unit may calculate the index based on a difference (amount of change) between the characteristics of the blood pressure waveform in the pre-exercise section and the characteristics of the blood pressure waveform in the post-exercise section, may calculate the index based on a time period until the characteristics of the blood pressure waveform changed by the exercise return to the state in the pre-exercise section, or may calculate the index based on a speed at which the characteristics of the blood pressure waveform changed by the exercise return to the state in the pre-exercise section. Further, these may be appropriately combined. As described above, the amount of change in the blood pressure waveform, the recovery time, the recovery speed, and the like depend on the content of the exercise performed or the characteristics relating to the cardiac function of the user. Therefore, by paying attention to at least the amount of change in the blood pressure waveform, the recovery time, and the recovery speed, the influence of the motion on the cardiac function of the user can be appropriately evaluated.
The Index extraction unit may use at least one of characteristics of AI (Augmentation Index), systolic blood pressure, diastolic blood pressure, mean blood pressure, heart rate, time difference between systolic blood pressure and post-systolic blood pressure as the characteristic of the blood pressure waveform. This is because these features have the property of temporarily changing (decreasing or increasing) due to the motion and gradually returning to the original state after the motion.
The processing portion may evaluate a degree of influence of the exercise on cardiac function based on the index and an index related to the intensity and/or duration of the exercise. Further, the processing section may perform processing for outputting the information of the degree of influence. By providing such information, the user can objectively and convincing grasp the exercise performed by himself or the influence of the exercise on his or her heart function.
The present invention may be considered as a biological information analysis device or system having at least a part of the above-described configuration or function. The present invention can be regarded as a biological information analysis method including at least a part of the above-described processing, a program for causing a computer to execute such a method, or a nonvolatile computer-readable recording medium on which such a program is recorded. Each of the above-described constitution and processes may be combined with each other to constitute the present invention as long as a technical contradiction is not created.
Effects of the invention
According to the present invention, a new technique for evaluating the degree of influence of motion on cardiac function based on data of blood pressure waveform can be provided.
Drawings
Fig. 1 is a diagram showing a schematic configuration of an external appearance of a biological information analysis system 10.
Fig. 2 is a block diagram showing a hardware configuration of the biological information analysis system 10.
Fig. 3 is a cross-sectional view schematically showing the structure of the blood pressure measuring unit 20 and the state during measurement.
Fig. 4 is a diagram showing a blood pressure waveform measured by the blood pressure measurement unit 20.
Fig. 5 is a block diagram for explaining the processing of the biological information analysis device 1.
Fig. 6 is a diagram showing a waveform (blood pressure waveform) of a pressure pulse wave of a radial artery with one heartbeat.
Fig. 7 is a flowchart of the process of evaluating the effect of exercise on cardiac function in example 1.
Fig. 8 is a diagram showing the blood pressure waveform and the change in the feature quantity F in the pre-exercise section, the target section (exercise section), and the post-exercise section in example 1.
Fig. 9 is a diagram showing an example of a determination chart of the evaluation result in example 1.
Fig. 10 is a diagram showing an example of evaluation result data in example 1.
Fig. 11 is a diagram showing an example of the index T, V when the AI value is used as the characteristic amount F of the blood pressure waveform in example 1.
Fig. 12 is a diagram showing an example of an information output screen.
Fig. 13 is a diagram showing an example of an information output screen.
Detailed Description
Hereinafter, preferred embodiments of the present invention will be described with reference to the drawings. The following description of each configuration is to be appropriately changed depending on the configuration of an apparatus to which the present invention is applied and various conditions, and is not intended to limit the scope of the present invention to the following description.
< biological information analysis System >
Fig. 1 is a diagram showing a schematic configuration of an external appearance of a biological information analysis system 10 according to an embodiment of the present invention. Fig. 1 shows a state in which the biological information analysis system 10 is worn on the left wrist. The biological information analysis system 10 includes a main body 11 and a belt 12 fixed to the main body 11. The biological information analysis system 10 is a so-called wearable device, and is worn such that the main body portion 11 is in contact with the skin on the inner side of the wrist and the main body portion 11 is disposed on the radial artery TD existing under the skin. In the present embodiment, the device is configured to be worn on the radial artery TD, but may be configured to be worn on another superficial artery.
Fig. 2 is a block diagram showing a hardware configuration of the biological information analysis system 10. The biological information analysis system 10 generally includes a measurement unit 2 and a biological information analysis device 1. The measurement unit 2 is a device that obtains information for analyzing biological information by measurement, and includes a blood pressure measurement unit 20, a body movement measurement unit 21, and an environment measurement unit 22. However, the configuration of the measurement unit 2 is not limited to the configuration shown in fig. 2. For example, a unit for measuring biological information (body temperature, blood glucose, brain waves, and the like) other than blood pressure and body movement may be added. Alternatively, since a unit not used in the embodiment described later is not necessarily configured, it may not be mounted on the biological information analysis system 10. The biological information analysis device 1 is a device that analyzes biological information based on information obtained from the measurement unit 2, and includes a control unit 23, an input unit 24, an output unit 25, a communication unit 26, and a storage unit 27. The units 20-27 are interconnected to exchange signals via a local bus or other signal line. Further, the biological information analysis system 10 has a power source (battery) not shown.
The blood pressure measuring unit 20 is a unit that measures the pressure pulse wave of the radial artery TD by a tensiometry. The tensiometry is a method of non-invasively measuring a pressure pulse wave by a pressure sensor by pressing an artery from above the skin with an appropriate pressure to form a flattened portion on the artery TD to achieve an equilibrium between the intra-arterial pressure and the external pressure.
The body movement measurement unit 21 includes a three-axis acceleration sensor, and is a unit that measures the movement of the user's body (body movement) by the sensor. The body movement measurement unit 21 may comprise circuitry for converting the output of the three-axis acceleration sensor into a format readable by the control unit 23.
The environment measurement unit 22 is a unit for measuring environment information that affects the physical and mental state (particularly, blood pressure) of the user. The environment measuring unit 22 may include, for example, an air temperature sensor, a humidity sensor, an illuminance sensor, an altitude sensor, a position sensor, and the like. The environment measurement unit 22 may include circuitry for converting the outputs of these sensors and the like into a format readable by the control unit 23.
The control unit 23 is a unit responsible for various processes, such as controlling each part of the biological information analysis system 10, acquiring data from the measurement unit 2, storing the acquired data in the storage unit 27, processing/analysis of data, input and output of data, and the like. The control unit 23 includes a hardware processor (hereinafter, referred to as a CPU), a ROM (Read Only Memory), a RAM (Random Access Memory), and the like. The processing of the control unit 23 described later is realized by the CPU reading a program stored in the ROM or the storage unit 27. The RAM is used as a work memory when the control unit 23 performs various processes. In the present embodiment, the control unit 23 is configured to execute the acquisition of data from the measurement unit 2 and the storage of data in the storage unit 27, but may be configured to directly store (write) data in the storage unit 27 from the measurement unit 2.
The components of the embodiment, for example, the measurement unit, the index extraction unit, the processing unit, the determination unit, the risk database, the input unit, the output unit, and the case database, may be installed in the biological information analysis system 10 in the form of hardware. The index extraction section, the processing section, and the determination section may receive an executable program stored in the storage unit 27 to execute. The index extraction section, the processing section, and the determination section may receive data from the blood pressure measurement unit 20, the body movement measurement unit 21, the environment measurement unit 22, the input unit 24, the output unit 25, the communication unit 26, the storage unit 27, and the like as necessary. Databases such as risk databases and case databases may be installed in the storage unit 27 or the like, storing information organized so that data can be easily retrieved and accumulated. Here, for example, japanese patent application No. 2016-. The content of which is incorporated by reference in the present specification. Further, japanese patent laid-open No. 2016-. The content of which is incorporated by reference in the present specification.
The input unit 24 is a unit for providing an operation interface to the user. For example, an operation button, a switch, a touch panel, or the like may be used.
The output unit 25 is a unit for providing an interface for outputting information to a user. For example, a display device (a liquid crystal display or the like) which outputs information by an image, a sound output device or a buzzer which outputs information by sound, an LED which outputs information by blinking of light, a vibration device which outputs information by vibration, or the like can be used.
The communication unit 26 is a unit that performs data communication with other devices. As a data communication method, any method such as wireless LAN, Bluetooth (registered trademark) or the like can be used.
The storage unit 27 is a storage medium capable of storing and reading data for storing a program executed in the control unit 23, measurement data obtained from each measurement unit, various data obtained by processing the measurement data, and the like. The storage unit 27 is a medium that accumulates information to be stored by an electric, magnetic, optical, mechanical, or chemical action. For example, a flash memory is used. The storage unit 27 may be a portable unit such as a memory card, or may be built in the biological information analysis system 10.
Some or all of the body movement measurement unit 21, the environment measurement unit 22, the control unit 23, the input unit 24, the output unit 25, and the storage unit 27 may be constituted by a device different from the main body portion 11. That is, as long as the main body 11 incorporating the blood pressure measuring unit 20 and the circuits for controlling the blood pressure measuring unit can be worn on the wrist, the configuration of the other units can be freely designed. In this case, the main body portion 11 cooperates with another unit through the communication unit 26. For example, various configurations are conceivable in which the functions of the control unit 23, the input unit 24, and the output unit 25 are configured by an application of a smartphone, or necessary data is acquired from an activity meter having the functions of the body movement measurement unit 21 and the environment measurement unit 22. Further, a sensor for measuring biological information other than blood pressure may be provided. For example, a sleep sensor, pulse oximeter (SpO) may be combined2Sensors), respiration sensors (flow sensors), blood glucose sensors, and the like.
In the present embodiment, the sensor for measuring blood pressure (blood pressure measuring means 20) and the structure (control means 23 and the like) for analyzing and processing blood pressure waveform data are provided in one device, but they may be separately provided. In the present embodiment, a configuration (such as the control unit 23) for performing analysis processing of biological information is referred to as a biological information analysis device, and a device configured by a combination of a measurement unit and a biological information analysis device is referred to as a biological information analysis system. However, the names are for convenience, and all of the configurations of the measurement unit and the analysis processing of the biological information may be referred to as biological information analysis devices, or other names may be used.
< measurement of blood pressure waveform >
Fig. 3 is a cross-sectional view schematically showing the structure of the blood pressure measuring unit 20 and the state during measurement. The blood pressure measuring unit 20 includes a pressure sensor 30 and a pressing mechanism 31 for pressing the pressure sensor 30 against the wrist. The pressure sensor 30 has a plurality of pressure detecting elements 300. The pressure detection element 300 is an element for detecting pressure and converting it into an electric signal, and for example, an element utilizing piezoresistive effect or the like can be preferably used. The pressing mechanism 31 is constituted by, for example, a bag and a pump for adjusting the internal pressure of the bag. When the control unit 23 controls the pump to increase the internal pressure of the air bag, the pressure sensor 30 is pressed against the skin surface due to the inflation of the air bag. The pressing mechanism 31 may be any mechanism that can adjust the pressing force of the pressure sensor 30 against the skin surface, and is not limited to the use of an air bag.
When the biological information analysis system 10 is worn on the wrist and started, the control unit 23 controls the pressing mechanism 31 of the blood pressure measurement unit 20 to maintain the pressing force of the pressure sensor 30 in an appropriate state (tension state). Then, the pressure signal detected by the pressure sensor 30 is sequentially acquired by the control unit 23. The analog physical quantity (for example, a voltage value) output from the pressure detection element 300 is digitized by an a/D conversion circuit or the like of a well-known technique, thereby generating a pressure signal obtained by the pressure sensor 30. The analog physical quantity may be an appropriate analog value such as a current value or a resistance value depending on the type of the pressure detection element 300. The signal processing such as a/D conversion may be performed by providing a predetermined circuit in the blood pressure measurement unit 20, or may be performed by another unit (not shown) provided between the blood pressure measurement unit 20 and the control unit 23. The pressure signal acquired by the control unit 23 corresponds to an instantaneous value of the internal pressure of the radial artery TD. Therefore, by acquiring the pressure signal continuously with time granularity which can grasp the blood pressure waveform of one heartbeat, time-series data of the blood pressure waveform can be acquired. The control unit 23 stores the pressure signals sequentially acquired by the pressure sensor 30 in the storage unit 27 together with information on the measurement time thereof. The control unit 23 may store the acquired pressure signal directly in the storage unit 27, or may store the pressure signal in the storage unit 27 after performing necessary signal processing on the pressure signal. The required information processing may include, for example, processing of calibrating the pressure signal so that the amplitude of the pressure signal coincides with the blood pressure value (e.g., upper arm blood pressure), processing of reducing or removing noise of the pressure signal, and the like.
Fig. 4 shows a blood pressure waveform measured by the blood pressure measuring unit 20. The horizontal axis is time and the vertical axis is blood pressure. The sampling frequency can be arbitrarily set, but is preferably set to 100Hz or more in order to reproduce the shape characteristics of the waveform of one heartbeat. Since the period of one heart beat is about 1 second, about 100 or more data points are acquired for the waveform of one heart beat.
The blood pressure measuring unit 20 of the present embodiment has the following advantages.
The blood pressure waveform of each heartbeat can be measured. Thus, for example, various indicators relating to blood pressure, heart state, cardiovascular risk, and the like can be obtained based on the shape characteristics of the blood pressure waveform. Further, since the instantaneous value of the blood pressure can be monitored, it is possible to detect the blood pressure fluctuation (rapid rise of the blood pressure value) immediately or to detect the blood pressure fluctuation and the disturbance of the blood pressure waveform occurring in a very short time (one to several heartbeats) without omission.
As a portable sphygmomanometer, a sphygmomanometer of a type that is worn on a wrist or an upper arm and measures blood pressure by an oscillometric method is practically used. However, in the conventional portable sphygmomanometer, the average value of the blood pressure can be measured only from the fluctuation of the cuff internal pressure of a plurality of heart beats between several seconds and ten seconds, and the time series data of the blood pressure waveform per one heart beat cannot be obtained as in the blood pressure measuring unit 20 of the present embodiment.
Time series data of the blood pressure waveform may be recorded. By acquiring time-series data of a blood pressure waveform, for example, various indexes related to blood pressure or heart state, cardiovascular risk, and the like can be obtained by grasping features regarding time variation of the blood pressure waveform, or by performing frequency analysis on the time-series data to extract specific frequency components.
Since the device is of a portable (wearable) type, the burden of measurement on the user is small, and it is relatively easy to perform continuous measurement for a long time, and further to perform blood pressure monitoring for 24 hours. Further, since it is portable, it is possible to measure not only the blood pressure at rest but also the change in blood pressure in free movement (for example, in daily life or exercise). This makes it possible to grasp the influence of, for example, movement (sleep, meal, commute, work, medicine taking, etc.) or exercise on blood pressure in daily life.
The conventional product is a device of a type in which an arm and a wrist are fixed to a blood pressure measurement unit and measurement is performed in a stationary state, and it is impossible to measure a blood pressure change in daily life or exercise as in the biological information analysis system 10 of the present embodiment.
Easily combined or coordinated with other sensors. For example, evaluation and integrated evaluation can be performed with information obtained by other sensors (environmental information such as body movement, temperature, SpO, etc.), and2and other biological information such as respiration).
< biological information analysis device >
Fig. 5 is a block diagram for explaining the processing of the biological information analysis device 1. As shown in fig. 5, the biological information analysis device 1 includes an index extraction unit 50 and a processing unit 51. In the present embodiment, the processes of the index extraction section 50 and the processing section 51 can be realized by executing a necessary program by the control unit 23. The program may be stored in the storage unit 27. When the control unit 23 executes a necessary program, the program to be an object stored in the ROM or the storage unit is developed in the RAM. Then, the control unit 23 interprets and executes the program developed in the RAM by the CPU, thereby controlling each constituent element. Part or all of the processing of the index extraction unit 50 and the processing unit 51 may be constituted by circuits such as an ASIC and an FPGA. Alternatively, a part or all of the processes in the index extraction section 50 and the processing section 51 may be realized by a computer (for example, a smartphone, a tablet terminal, a personal computer, a cloud service, or the like) separate from the main body section 11.
The index extraction unit 50 acquires time-series data of blood pressure waveforms continuously measured by the blood pressure measurement unit 20 from the storage unit 27. The index extraction unit 50 extracts an index relating to a blood pressure waveform feature from the acquired time-series data of the blood pressure waveform. Here, the characteristics of the blood pressure waveform include shape characteristics of the blood pressure waveform of one heartbeat, temporal changes of the blood pressure waveform, frequency components of the blood pressure waveform, and the like. However, the characteristics of the blood pressure waveform are not limited thereto. The extracted index is output to the processing unit 51. There are various characteristics and indices of the blood pressure waveform, and the characteristics and indices to be extracted may be appropriately designed or selected according to the purpose of processing by the processing section 51. Features and indices extractable from the measurement data of the blood pressure waveform of the present embodiment will be described in detail later.
When acquiring the index, the index extraction section 50 may use the measurement data of the body movement measurement unit 21 and/or the measurement data of the environment measurement unit 22 in addition to the measurement data of the blood pressure waveform. Further, although not shown, a sleep sensor, SpO, may also be combined2Measurement data of a sensor, a respiration sensor (flow sensor), a blood glucose sensor, and the like. By comprehensively analyzing a variety of measurement data obtained by a variety of sensors, more sophisticated information analysis of the blood pressure waveform can be performed. The blood pressure waveform data may be classified for each state of the user, such as at rest and at motion, at high and low temperature, at light and deep sleep, at breathing and at apnea. Alternatively, it can also be evaluatedThe causal relationship and correlation of each measurement data, such as extracting the influence of body movement, activity amount and activity intensity, temperature change, apnea, breathing pattern, etc. on blood pressure.
The processing unit 51 receives the index extracted by the index extraction unit 50. The processing unit 51 performs processing based on the received index. Various processes can be conceived among the index-based processes. For example, the processing unit 51 may present the value, change, and the like of the extracted index to the user, a doctor, a health care professional, and the like, and encourage use in health management, treatment, health care guidance, and the like. Alternatively, the processing unit 51 may estimate cardiovascular risk from the extracted index, or present a guideline for maintaining health or improving risk. When an increase in cardiovascular risk is detected or predicted based on the index, the processing unit 51 may notify the user, the attending physician, or the like, or perform control for preventing an action that is a burden on the heart or the like of the user or occurrence of a cardiovascular event.
< information obtained from blood pressure waveform >
Fig. 6 shows a waveform (blood pressure waveform) of a pressure pulse wave of a radial artery of one heartbeat. The horizontal axis represents time t [ msec ], and the vertical axis represents blood pressure BP [ mmHg ].
The blood pressure waveform is a composite wave of a "forward wave" generated when the heart contracts and sends blood and a "reflected wave" generated when the forward wave is reflected by a branch portion of a peripheral blood vessel or an artery. An example of characteristic points that can be extracted from a blood pressure waveform of one heartbeat is shown below.
The point F1 is the rising point of the pressure pulse wave. Point F1 corresponds to the starting point of the cardiac ejection, i.e. the opening point of the aortic valve.
Point F2 is the point (first peak) at which the amplitude (pressure) of the forward wave is maximum.
The point F3 is an inflection point that appears on the way of the forward wave descent due to the overlapping of the reflected waves.
Point F4 is the minimum point occurring between the forward wave and the reflected wave, also called the notch. This corresponds to the closing point of the aortic valve.
The point F5 is the peak (second peak) of the reflected wave that appears after the point F4.
Point F6 is the end point of one heartbeat, corresponding to the ejection start point of the next heartbeat, i.e. the start point of the next heartbeat.
The index extraction section 50 may use any algorithm to detect the above-described feature points. For example, the index extraction unit 50 may extract a characteristic point (inflection point) of the blood pressure waveform by calculating an n-order differential waveform of the blood pressure waveform and detecting a zero-crossing point thereof (for points F1, F2, F4, F5, and F6, it may be detected from a first-order differential waveform, and for point F3, it may be detected from a second-order differential waveform or a fourth-order differential waveform). Alternatively, the index extraction unit 50 may read a waveform pattern in which the feature points are arranged in advance from the storage unit 27, and determine the positions of the feature points by fitting the waveform pattern to the blood pressure waveform targeted for the feature points.
Based on the time t and the pressure BP of the feature points F1 to F6, the index extraction unit 50 can calculate various information (values, feature values, indexes, and the like) from the blood pressure waveform of one heartbeat. Hereinafter, representative information among information obtainable from a blood pressure waveform is exemplified. Tx and BPx represent the time and blood pressure of the feature point Fx, respectively.
Pulse wave interval (heart cycle) TA ═ t6-t1
Heart rate PR ═ 1/TA
The pulse wave rise time UT-t 2-t1
Contraction period TS ═ t4-t1
Diastolic time TD ═ t6-t4
The reflected wave delay time t3-t1
Hypertension (systolic blood pressure) SBP ═ BP2
The lowest blood pressure (diastolic blood pressure) DBP ═ BP1
Area of blood pressure waveform/cardiac cycle TA of t1 to t6 average blood pressure MAP
Systolic mean blood pressure (t 1-t 4) area of blood pressure waveform/systolic TS
Mean blood pressure in diastolic phase (area of blood pressure waveform from t4 to t 6)/diastolic phase TD
Pulse pressure PP ═ hypertension SBP-hypotension DBP
Post-shrink compression SBP2 ═ BP3
AI (Augmentation Index) (post-systolic pressure SBP 2-hypotension DBP)/pulse pressure PP
Basic statistics of these pieces of information (values, feature quantities, indices) can also be used as indices. The basic statistical quantities include, for example, representative values (mean value, median value, mode value, maximum value, minimum value, etc.), degrees of dispersion (variance, standard deviation, coefficient of variation, etc.). In addition, temporal changes in these pieces of information (values, characteristic values, indices) can also be used as indices.
Further, the index extraction section 50 may obtain an index of BRS (blood pressure regulation ability) by calculating a plurality of pieces of heartbeat information. This is an index indicating the ability to regulate blood pressure to be constant. The calculation method may be, for example, a Spontaneous sequence (Spontaneous sequence) method or the like. The method comprises the steps of extracting sequences of synchronous rising or falling of the SBP and the TA of the pulse wave of the hypertension which is more than three continuous heartbeats, drawing the SBP and the TA of the pulse wave on a two-dimensional plane, and defining the slope of a regression line obtained by a least square method as BRS.
As described above, by using the biological information analysis system 10 of the present embodiment, various kinds of information can be acquired from the data of the blood pressure waveform. It is not necessary to install a function for acquiring all of the above information in the biological information analysis system 10. Depending on the configuration of the biological information analysis system 10, the user, the purpose of use, the place of use, and the like, only a function for acquiring necessary information may be installed. Each function may be provided as a program module (application software), and the necessary program module may be installed in the biological information analysis system 10 to add the function.
Hereinafter, an example of a specific application of the biological information analysis system 10 will be exemplarily described.
< example 1 >
The present invention relates to a method for assessing and visualizing the effect of motion on the cardiac function of a user based on time series data of blood pressure waveforms.
It is known that exercise is effective for improvement of blood pressure, but it is difficult for the user himself to imagine how much exercise has an effect on himself. In addition, excessive exercise may be a burden on the body, but it is difficult to know how much the exercise is being performed on the heart of the user.
The present inventors observed the change in the blood pressure waveform before and after exercise in an experiment of a subject, and confirmed the following phenomenon. (1) The blood pressure waveform temporarily changes due to the movement, and gradually returns to the original state after the movement is finished. (2) The amount of change in the blood pressure waveform and the recovery time (recovery speed) vary depending on the activity amount of the exercise performed. (3) In addition, the amount of change in the blood pressure waveform and the recovery time (recovery speed) also vary depending on the cardiovascular characteristics of a human. Based on such knowledge, an algorithm for evaluating the degree of influence of motion on cardiac function based on time-series data of a blood pressure waveform is provided in the present embodiment.
The biological information analysis device 1 of the present embodiment estimates the cardiovascular characteristics of the user by estimating the change in the blood pressure waveform before and after exercise using the feature amount extracted from the blood pressure waveform for each heartbeat. As the characteristic amount of the blood pressure waveform, for example, AI (Augmentation Index), systolic blood pressure SBP, diastolic blood pressure DBP, mean blood pressure MAP, heart rate PR, time difference DTp between systolic blood pressure SBP and systolic post-pressure SBP2 (t 3-t2 in fig. 6), and the like can be used. Of these feature values, AI, SBP, DBP, and MAP show actions of temporarily decreasing due to motion and then gradually increasing and returning to the original values. On the other hand, PR and DTp show actions of gradually decreasing and returning to the original states after temporarily increasing due to the movement. By accurately monitoring the blood pressure waveform per heartbeat in the free movement, such a change in the characteristic amount can be grasped at the first time. In other words, from blood pressure data obtained from a sphygmomanometer of a type that cannot measure a blood pressure waveform like the oscillometric method and blood pressure data measured at rest, the change in the feature amount as described above cannot be grasped.
The flow of the processing of the present embodiment is explained with reference to the flowchart of fig. 7. However, as a premise, it is assumed that time-series data of the blood pressure waveform measured by the blood pressure measuring unit 20 and time-series data of the activity intensity [ METs ] measured by the body movement measuring unit 21 are accumulated in the storage unit 27 or other data storage (including a cloud server).
The index extraction unit 50 reads time-series data of the blood pressure waveform and time-series data of the activity intensity from the storage unit 27 or other data memory (step 4800). Then, the index extraction unit 50 detects a section in which exercise is performed from the time-series data of the activity intensity, and marks a section in which exercise is to be set as an evaluation target (step 4801). For example, a section satisfying the following conditions (1) to (3) is designated as an evaluation target.
(1) Exercise (e.g., a state in which the activity intensity is greater than 1 METs) continues for a time Tth1 or more. The activity intensity may be not only the METs but also other indicators (for example, METs × body weight, etc.) indicating the activity intensity.
(2) The activity (Ex) in the entire interval is equal to or higher than the threshold value Eth. Here, the Ex amount (exercise amount) is a value of the activity intensity [ METs ] multiplied by the activity time.
(3) Before and after this interval, a non-moving interval (for example, an interval in which a state in which the activity intensity is 1METs or less continues) having a length of not less than Tth2 exists.
The condition (2) may be determined not by the amount of activity but by other indicators related to the exercise (for example, statistics of the exercise intensity (average, maximum, most frequent value, etc.) or calorie consumption in the section). The threshold value Tth1 is set to a time longer than at least the minimum time unit in which the activity intensity can be measured. In addition, the threshold Tth2 is set to a length to such an extent that the motion performed in the other section does not affect the evaluation. The threshold values Tth1, Tth2, Eth used for the above determination processing are stored in advance in, for example, the storage unit 27.
Hereinafter, the motion section marked as the evaluation target is referred to as a "target section", the activity amount of the target section is Ea, and the activity time (length) is Ta.
Then, the index extraction unit 50 acquires blood pressure waveform data of a non-moving section immediately before the target section (referred to as a "pre-moving section") and blood pressure waveform data of a non-moving section immediately after the target section (referred to as a "post-moving section") from the time-series data of the blood pressure waveform (step 4802). The lengths of the pre-exercise interval and the post-exercise interval may be set arbitrarily (the longest length is not more than Tth 2). Fig. 8 shows the blood pressure waveform and the change in the characteristic amount F thereof in the pre-exercise section, the target section (exercise section), and the post-exercise section. Fig. 8 shows an example of using an AI value as the characteristic amount F of the blood pressure waveform.
The index extraction unit 50 calculates a value F1 of the feature quantity F before the exercise based on the blood pressure waveform data of the pre-exercise section (step 4803). For example, the value F1 is an average value, a most frequent value, a median value, or the like of the feature quantity F of the pre-movement section. Further, the index extraction unit 50 calculates a minimum value F2 of the feature quantity F in the post-exercise section based on the blood pressure waveform data of the post-exercise section (step 4804). Then, the index extraction section 50 calculates the change amount DF (═ F1-F2|) (step 4805). The index DF indicates how much the blood pressure waveform has changed due to the movement performed in the target section, and can be used as an index indicating the influence of the movement on the cardiac function of the user. If the feature quantity (for example, PR, DTp, or the like) increases due to the motion, the maximum value F2 of the feature quantity F in the post-motion section may be calculated in step 4804.
Then, the processing unit 51 evaluates the degree of influence of the exercise on the cardiac function based on the activity amount Ea and the index DF in the target section (step 4806). In the present embodiment, any one of Low (degree of influence: small), Mid (degree of influence: medium), and High (degree of influence: large) values is output as the evaluation result R. For example, when the index DF is small (the amount of change in the feature quantity F is small) although the activity amount Ea is large, it is estimated that the cardiac function is hardly affected by the motion. Fig. 9 is an example of a determination chart of the evaluation result R used by the processing unit 51. The horizontal axis represents the value of index DF, and the vertical axis represents the activity [ Ex ]. The reference or determination chart for evaluation is merely an example, and other methods may be used. Also, for example, there may be soft classification, continuous value evaluation instead of three-phase evaluation.
For example, the processing unit 51 generates evaluation result data in which information of the target section (the date and time of the start of exercise, the amount of activity Ea, and the activity time Ta), information of the pre-exercise section and the post-exercise section (the feature amounts F1 and F2), the degree of influence index (DF), and the evaluation result (R) are associated with each other, and stores the evaluation result data in the storage unit 27 (step 4807). If a plurality of target sections are extracted in step 4800, the processing of steps 4802 to 4807 is repeated for each target section.
Fig. 10 is an example of evaluation result data accumulated in the storage unit 27. By accumulating such evaluation result data, it is possible to objectively grasp how much the degree of exercise has largely affected the heart function of the user. In this way, for example, the user knows how much exercise the user's own heart function is currently being affected by, so that the effect of motor therapy can be imagined and the motivation for continuous exercise can be increased. Furthermore, the user may be aware of the exercise regimen for his or her own risks and may select a reasonable exercise regimen that suits his or her cardiovascular characteristics. Furthermore, a doctor or healthcare professional can guide the appropriate exercise therapy matching the cardiovascular characteristics of the user by utilizing such data.
(modification example)
As an index indicating the influence of exercise on the cardiac function, the following index may be used in addition to the change amount DF of the feature quantity F.
Time T required for the feature quantity F changed by the movement to return to the state of the pre-movement section
The speed V at which the characteristic amount F changed by the movement returns to the state of the pre-movement section
The index T, V is an index indicating the restoring force of the cardiac function of the user. Fig. 11 shows an example of the index T, V when an AI value is used as the feature quantity F of the blood pressure waveform. The index T, V is calculated as follows.
T=T3-T2
V=|F3-F2|/|T3-T2|
Here, T2 is the time at which the feature value F is minimum in the post-exercise section, and F2 is the value of the feature value at time T2. T3 is the time at which the feature value F returns to the value F1 before the motion in the section after the motion, and F3 is the value of the feature value at the time T3. It should be noted that a certain margin may be set to determine whether or not to recover. For example, it is determined as "recovered" or the like, considering that the difference or ratio between the value F1 of the feature amount before the movement and the value F3 of the feature amount after the movement falls within a predetermined range. Note that, when Te is the end time of the target section (the time at which the movement is ended), the index T, V can be obtained as follows.
T=T3-Te
V=|F3-Fe|/|T3-Te|
Fe is the value of the characteristic amount at time Te.
Like index DF, the use of index T, V also allows assessment of the degree of influence motion has on cardiac function. In the evaluation of the degree of influence, a plurality of indexes may be used. For example, in fig. 9, a two-axis graph of the activity amount Ea and the index DF is used, but the influence degree may be determined by a three-axis graph of the activity amount Ea, the index DF, and the index T, or by a four-axis graph of the activity amount Ea, the index DF, the index T, and the index V. The combination and number of the indices used for the determination are arbitrary.
(output example)
The processing section 51 may output information obtained by the above-described evaluation processing to the output unit 25 or an external display device or the like (not shown). Fig. 12 is an example of an information output screen of the processing unit 51. The upper part shows a graph of information on the exercise section (activity Ea), the blood pressure waveform and the characteristic value (AI value) in the pre-exercise section and the post-exercise section, and the lower part shows a graph showing the evaluation result (asterisk) of the exercise section. By observing such a screen, the user can easily grasp the degree of influence of the exercise performed on the heart function of the user. Fig. 13 is another example of the information output screen of the processing unit 51. The evaluation results (asterisks) related to the motions of a plurality of times (4 times in the example of fig. 13) are arranged in time series and displayed on a graph. By observing such a screen, the user can intuitively grasp the change in the degree of influence of the exercise performed on the heart function of the user.
The configuration of the above embodiments and examples is only one specific example of the present invention, and is not intended to limit the scope of the present invention. The present invention may be embodied in various specific configurations without departing from the technical spirit thereof.
The technical idea disclosed in the present specification can also be determined as the following invention.
(appendix 1)
A biological information analysis device is characterized in that,
having a hardware processor and a memory for storing programs,
the hardware processor is connected with the computer through the program,
acquiring data of a blood pressure waveform in a pre-exercise section before exercise by a user and data of a blood pressure waveform in a post-exercise section after the exercise by the user from time-series data of blood pressure waveforms continuously measured by a sensor that is worn on a body of the user and is capable of non-invasively measuring a blood pressure waveform for each heartbeat,
extracting an index representing an influence of the motion on a cardiac function of the user based on the feature of the blood pressure waveform in the pre-motion section and the feature of the blood pressure waveform in the post-motion section,
and performing processing based on the extracted index.
(appendix 2)
A biological information analysis system characterized in that,
comprising: a sensor worn on the body of the user and capable of non-invasively measuring the blood pressure waveform for each heartbeat; a hardware processor; and a memory for storing a program, and,
the hardware processor is connected with the computer through the program,
acquiring data of a blood pressure waveform in a pre-exercise section before exercise by a user and data of a blood pressure waveform in a post-exercise section after the exercise by the user from time-series data of blood pressure waveforms continuously measured by a sensor that is worn on a body of the user and is capable of non-invasively measuring a blood pressure waveform for each heartbeat,
extracting an index representing an influence of the motion on a cardiac function of the user based on the feature of the blood pressure waveform in the pre-motion section and the feature of the blood pressure waveform in the post-motion section,
and performing processing based on the extracted index.
(appendix 3)
A biological information analysis method, comprising:
a step of acquiring, by at least one hardware processor, data of a blood pressure waveform in a pre-exercise section before exercise by a user and data of a blood pressure waveform in a post-exercise section after the user performs the exercise, from time-series data of blood pressure waveforms continuously measured by a sensor that is worn on the body of the user and is capable of non-invasively measuring a blood pressure waveform for each heartbeat;
a step of extracting, by at least one hardware processor, an index representing an influence of the exercise on a cardiac function of the user based on the feature of the blood pressure waveform in the pre-exercise section and the feature of the blood pressure waveform in the post-exercise section; and
and a step of performing, by at least one hardware processor, processing based on the extracted index.
Description of the reference numerals
1: biological information analysis device, 2: measuring unit
10: biological information analysis system, 11: main body portion, 12: belt
20: blood pressure measurement unit, 21: body movement measurement unit, 22: environment measurement unit, 23: control unit, 24: input unit, 25: output unit, 26: communication unit, 27: memory cell
30: pressure sensor, 31: pressing mechanism, 300: pressure detecting element
50: index extraction unit, 51: treatment section
Claims (10)
1. A biological information analysis device is characterized by comprising:
an index extraction unit that acquires data of a blood pressure waveform in a pre-exercise section before exercise by a user and data of a blood pressure waveform in a post-exercise section after the exercise by the user from time-series data of blood pressure waveforms continuously measured by a sensor that is worn on a body of the user and can non-invasively measure a blood pressure waveform per heartbeat, and extracts an index indicating an influence of the exercise on a cardiac function of the user based on a feature of the blood pressure waveform in the pre-exercise section and a feature of the blood pressure waveform in the post-exercise section; and
a processing unit that performs processing based on the extracted index,
the index extraction unit detects a section satisfying the following conditions (1) to (3) as a movement section in which the user has moved:
(1) the state that the activity intensity is larger than the first value is continuous for more than a first time;
(2) the activity level of the whole interval is above a specified threshold;
(3) there are intervals in which the state in which the activity intensity is equal to or lower than the first value continues for a second time or longer before and after,
the index extraction unit extracts the index based on an average value, a median value, or a mode of the characteristics of the blood pressure waveform in the pre-exercise section and a maximum value or a minimum value of the characteristics of the blood pressure waveform in the post-exercise section.
2. The biological information analysis device according to claim 1,
the index extraction unit calculates the index based on a difference between an average value, a median value, or a mode of the characteristics of the blood pressure waveform in the pre-exercise section and a maximum value or a minimum value of the characteristics of the blood pressure waveform in the post-exercise section.
3. The biological information analysis device according to claim 1,
the index extraction unit calculates the index based on a time until the feature of the blood pressure waveform in the post-exercise section is restored from a maximum value or a minimum value of the feature of the blood pressure waveform in the post-exercise section to an average value, a median value, or a mode value of the feature of the blood pressure waveform in the pre-exercise section.
4. The biological information analysis device according to claim 1,
the index extraction unit calculates the index based on a speed at which the feature of the blood pressure waveform in the post-exercise section is restored from the maximum value or the minimum value of the feature of the blood pressure waveform in the post-exercise section to the average value, the intermediate value, or the mode of the feature of the blood pressure waveform in the pre-exercise section.
5. The biological information analysis device according to claim 1,
the index extraction unit uses at least one of the characteristics of an emphasis index, systolic blood pressure, diastolic blood pressure, average blood pressure, heart rate, and time difference between systolic blood pressure and post-systolic blood pressure as the characteristic of the blood pressure waveform.
6. The biological information analysis device according to claim 1,
the processing portion evaluates a degree of influence of the exercise on cardiac function based on the index and an index relating to intensity and/or duration of the exercise.
7. The biological information analysis device according to claim 6,
the processing unit performs processing for outputting the information of the degree of influence.
8. A biological information analysis system comprising:
a sensor worn on the body of the user and capable of non-invasively measuring the blood pressure waveform for each heartbeat; and
the biological information analysis device according to any one of claims 1 to 7, wherein the biological information is analyzed using data of a blood pressure waveform continuously measured by the sensor.
9. A computer-readable storage medium storing a program characterized in that,
the program causes a processor to function as the index extraction unit and the processing unit of the biological information analysis device according to any one of claims 1 to 7.
10. A biological information analysis method, comprising:
an index extraction step of acquiring data of a blood pressure waveform in a pre-exercise section before exercise by a user and data of a blood pressure waveform in a post-exercise section after the exercise by the user from time-series data of blood pressure waveforms continuously measured by a sensor that is worn on a body of the user and capable of non-invasively measuring a blood pressure waveform per heartbeat, and extracting an index representing an influence of the exercise on a cardiac function of the user based on a feature of the blood pressure waveform in the pre-exercise section and a feature of the blood pressure waveform in the post-exercise section; and
a processing step of performing processing based on the extracted index,
in the index extraction step, a section satisfying the following conditions (1) to (3) is detected as a movement section in which the user has moved:
(1) the state that the activity intensity is larger than the first value is continuous for more than a first time;
(2) the activity level of the whole interval is above a specified threshold;
(3) there are intervals in which the state in which the activity intensity is equal to or lower than the first value continues for a second time or longer before and after,
in the extracting the index, the index is extracted based on an average value, a median value, or a mode of the features of the blood pressure waveform in the pre-exercise section and a maximum value or a minimum value of the features of the blood pressure waveform in the post-exercise section.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016-082463 | 2016-04-15 | ||
JP2016082463 | 2016-04-15 | ||
PCT/JP2017/015284 WO2017179703A1 (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device and system, and program |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108882873A CN108882873A (en) | 2018-11-23 |
CN108882873B true CN108882873B (en) | 2021-08-06 |
Family
ID=60041783
Family Applications (11)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780022529.5A Active CN108882868B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022566.6A Active CN108882871B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, program, and biological information analysis method |
CN201780022781.6A Active CN108882878B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022568.5A Active CN108882873B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022527.6A Active CN108882867B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022528.0A Active CN109069035B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and computer-readable storage medium |
CN201780022536.5A Active CN108882869B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022565.1A Active CN108882870B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022567.0A Active CN108882872B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, biological information analysis system, program, and biological information analysis method |
CN201780022537.XA Active CN108882877B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022530.8A Active CN109069013B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780022529.5A Active CN108882868B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022566.6A Active CN108882871B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, program, and biological information analysis method |
CN201780022781.6A Active CN108882878B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
Family Applications After (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780022527.6A Active CN108882867B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022528.0A Active CN109069035B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and computer-readable storage medium |
CN201780022536.5A Active CN108882869B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022565.1A Active CN108882870B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022567.0A Active CN108882872B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, biological information analysis system, program, and biological information analysis method |
CN201780022537.XA Active CN108882877B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
CN201780022530.8A Active CN109069013B (en) | 2016-04-15 | 2017-04-14 | Biological information analysis device, system, and program |
Country Status (5)
Country | Link |
---|---|
US (11) | US20190159723A1 (en) |
EP (11) | EP3427654A4 (en) |
JP (11) | JP6687263B2 (en) |
CN (11) | CN108882868B (en) |
WO (11) | WO2017179698A1 (en) |
Families Citing this family (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11328152B2 (en) * | 2019-06-17 | 2022-05-10 | Pixart Imaging Inc. | Recognition system employing thermal sensor |
US11253205B2 (en) * | 2017-08-16 | 2022-02-22 | Seiko Epson Corporation | Pulse pressure and blood pressure analysis device, pulse pressure and blood pressure analysis method, and program |
US11116414B2 (en) * | 2017-08-16 | 2021-09-14 | Seiko Epson Corporation | Biological analysis device, biological analysis method, and program |
JP7124460B2 (en) * | 2018-05-31 | 2022-08-24 | セイコーエプソン株式会社 | Biological analysis device, biological analysis method and program |
US11317873B2 (en) * | 2017-08-16 | 2022-05-03 | Seiko Epson Corporation | Biological analysis device, biological analysis method, and program |
CN107550481A (en) * | 2017-08-24 | 2018-01-09 | 京东方科技集团股份有限公司 | A kind of portable equipment and blood pressure measuring method |
CN109833037B (en) * | 2017-11-29 | 2022-05-17 | 华为终端有限公司 | Equipment for monitoring blood pressure state and computer readable storage medium |
JP2019115602A (en) * | 2017-12-27 | 2019-07-18 | オムロンヘルスケア株式会社 | Biological information measuring device, measurement control method, and program |
JP6897558B2 (en) * | 2017-12-27 | 2021-06-30 | オムロンヘルスケア株式会社 | Information processing equipment, information processing methods and information processing programs |
WO2019138327A1 (en) * | 2018-01-09 | 2019-07-18 | Shankar Rohini | Wearable ecg and auscultation monitoring system with sos and remote monitoring |
JP7091701B2 (en) * | 2018-02-22 | 2022-06-28 | オムロンヘルスケア株式会社 | Blood pressure measuring device, blood pressure measuring method and program, breathing support device |
WO2019176190A1 (en) | 2018-03-12 | 2019-09-19 | パラマウントベッド株式会社 | Electric furniture |
JP6626951B2 (en) * | 2018-03-12 | 2019-12-25 | パラマウントベッド株式会社 | Electric furniture |
KR102562817B1 (en) * | 2018-05-16 | 2023-08-02 | 삼성전자주식회사 | Electronic device for measuring blood pressure and operating method thereof |
AU2019283182B2 (en) * | 2018-06-05 | 2021-03-04 | Kazuo Tani | Blood flow volume measurement system |
WO2020037599A1 (en) * | 2018-08-23 | 2020-02-27 | 深圳迈瑞生物医疗电子股份有限公司 | Medical device, apnea event monitoring method and apparatus |
JP6988001B2 (en) * | 2018-08-30 | 2022-01-05 | オリンパス株式会社 | Recording device, image observation device, observation system, observation system control method, and observation system operation program |
KR102655676B1 (en) * | 2018-10-10 | 2024-04-05 | 삼성전자주식회사 | Apparatus and method for estimating blood pressure, and apparatus for supporting blood pressure estimation |
KR102657522B1 (en) * | 2018-11-06 | 2024-04-15 | 삼성전자주식회사 | Electronic device and method for identifying occurrence of hypotension |
CN109674474B (en) * | 2018-11-30 | 2021-12-03 | 深圳和而泰智能控制股份有限公司 | Sleep apnea recognition method, device and computer readable medium |
CN109731314B (en) * | 2019-01-25 | 2020-12-29 | 杨彬 | Cerebral infarction rehabilitation training device based on high in clouds |
DE102019102178A1 (en) | 2019-01-29 | 2020-07-30 | Fresenius Medical Care Deutschland Gmbh | Method for determining a patient's blood pressure value, blood pressure monitor and dialysis system |
JP7320807B2 (en) * | 2019-02-14 | 2023-08-04 | デルタ工業株式会社 | Physical condition determination device and computer program |
JP7127571B2 (en) * | 2019-02-18 | 2022-08-30 | オムロンヘルスケア株式会社 | Blood pressure level change detection device, blood pressure level change detection method, and program |
JP7225893B2 (en) * | 2019-02-18 | 2023-02-21 | オムロンヘルスケア株式会社 | Blood pressure value analysis support device, blood pressure value analysis support system, blood pressure value analysis support method, and program |
US12083380B2 (en) | 2019-03-11 | 2024-09-10 | Rom Technologies, Inc. | Bendable sensor device for monitoring joint extension and flexion |
US11541274B2 (en) | 2019-03-11 | 2023-01-03 | Rom Technologies, Inc. | System, method and apparatus for electrically actuated pedal for an exercise or rehabilitation machine |
JP6871546B2 (en) * | 2019-03-12 | 2021-05-12 | 群馬県 | Detection method and detection device for detecting abnormalities in pulse pressure waveform |
JP7326802B2 (en) * | 2019-03-25 | 2023-08-16 | オムロンヘルスケア株式会社 | Measurement facilitator, method and program |
JP7256049B2 (en) * | 2019-03-25 | 2023-04-11 | オムロンヘルスケア株式会社 | Blood pressure-related information display device, blood pressure-related information display method, and program |
JP7336510B2 (en) | 2019-04-12 | 2023-08-31 | 株式会社半導体エネルギー研究所 | Display device |
CN113811238B (en) * | 2019-05-08 | 2024-04-19 | 长桑数字技术(青岛)有限公司 | Sphygmomanometer, sphygmomanometer control method and method for detecting effective pulse wave |
US11957960B2 (en) | 2019-05-10 | 2024-04-16 | Rehab2Fit Technologies Inc. | Method and system for using artificial intelligence to adjust pedal resistance |
US11904207B2 (en) | 2019-05-10 | 2024-02-20 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to present a user interface representing a user's progress in various domains |
US11801423B2 (en) | 2019-05-10 | 2023-10-31 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to interact with a user of an exercise device during an exercise session |
US11433276B2 (en) | 2019-05-10 | 2022-09-06 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to independently adjust resistance of pedals based on leg strength |
US12102878B2 (en) | 2019-05-10 | 2024-10-01 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to determine a user's progress during interval training |
JP7328044B2 (en) * | 2019-07-22 | 2023-08-16 | マクセル株式会社 | Detection device and detection method |
KR102567952B1 (en) | 2019-09-11 | 2023-08-16 | 삼성전자주식회사 | Apparatus and method for estimating bio-information |
JP2021040969A (en) * | 2019-09-11 | 2021-03-18 | オムロンヘルスケア株式会社 | Method for generating determination algorithm, determination algorithm, determination system, determination method, program, and recording medium |
US11071597B2 (en) | 2019-10-03 | 2021-07-27 | Rom Technologies, Inc. | Telemedicine for orthopedic treatment |
US11701548B2 (en) | 2019-10-07 | 2023-07-18 | Rom Technologies, Inc. | Computer-implemented questionnaire for orthopedic treatment |
US12191018B2 (en) | 2019-10-03 | 2025-01-07 | Rom Technologies, Inc. | System and method for using artificial intelligence in telemedicine-enabled hardware to optimize rehabilitative routines capable of enabling remote rehabilitative compliance |
US12246222B2 (en) | 2019-10-03 | 2025-03-11 | Rom Technologies, Inc. | Method and system for using artificial intelligence to assign patients to cohorts and dynamically controlling a treatment apparatus based on the assignment during an adaptive telemedical session |
US12230381B2 (en) | 2019-10-03 | 2025-02-18 | Rom Technologies, Inc. | System and method for an enhanced healthcare professional user interface displaying measurement information for a plurality of users |
US11915815B2 (en) | 2019-10-03 | 2024-02-27 | Rom Technologies, Inc. | System and method for using artificial intelligence and machine learning and generic risk factors to improve cardiovascular health such that the need for additional cardiac interventions is mitigated |
US11069436B2 (en) | 2019-10-03 | 2021-07-20 | Rom Technologies, Inc. | System and method for use of telemedicine-enabled rehabilitative hardware and for encouraging rehabilitative compliance through patient-based virtual shared sessions with patient-enabled mutual encouragement across simulated social networks |
US11282599B2 (en) | 2019-10-03 | 2022-03-22 | Rom Technologies, Inc. | System and method for use of telemedicine-enabled rehabilitative hardware and for encouragement of rehabilitative compliance through patient-based virtual shared sessions |
US20210134458A1 (en) | 2019-10-03 | 2021-05-06 | Rom Technologies, Inc. | System and method to enable remote adjustment of a device during a telemedicine session |
US20230245750A1 (en) | 2019-10-03 | 2023-08-03 | Rom Technologies, Inc. | Systems and methods for using elliptical machine to perform cardiovascular rehabilitation |
US11270795B2 (en) | 2019-10-03 | 2022-03-08 | Rom Technologies, Inc. | Method and system for enabling physician-smart virtual conference rooms for use in a telehealth context |
US11955222B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for determining, based on advanced metrics of actual performance of an electromechanical machine, medical procedure eligibility in order to ascertain survivability rates and measures of quality-of-life criteria |
US12020799B2 (en) | 2019-10-03 | 2024-06-25 | Rom Technologies, Inc. | Rowing machines, systems including rowing machines, and methods for using rowing machines to perform treatment plans for rehabilitation |
US12327623B2 (en) | 2019-10-03 | 2025-06-10 | Rom Technologies, Inc. | System and method for processing medical claims |
US11282604B2 (en) | 2019-10-03 | 2022-03-22 | Rom Technologies, Inc. | Method and system for use of telemedicine-enabled rehabilitative equipment for prediction of secondary disease |
US12176089B2 (en) | 2019-10-03 | 2024-12-24 | Rom Technologies, Inc. | System and method for using AI ML and telemedicine for cardio-oncologic rehabilitation via an electromechanical machine |
US12062425B2 (en) | 2019-10-03 | 2024-08-13 | Rom Technologies, Inc. | System and method for implementing a cardiac rehabilitation protocol by using artificial intelligence and standardized measurements |
US11923065B2 (en) | 2019-10-03 | 2024-03-05 | Rom Technologies, Inc. | Systems and methods for using artificial intelligence and machine learning to detect abnormal heart rhythms of a user performing a treatment plan with an electromechanical machine |
US12020800B2 (en) | 2019-10-03 | 2024-06-25 | Rom Technologies, Inc. | System and method for using AI/ML and telemedicine to integrate rehabilitation for a plurality of comorbid conditions |
US11515028B2 (en) | 2019-10-03 | 2022-11-29 | Rom Technologies, Inc. | Method and system for using artificial intelligence and machine learning to create optimal treatment plans based on monetary value amount generated and/or patient outcome |
US11139060B2 (en) | 2019-10-03 | 2021-10-05 | Rom Technologies, Inc. | Method and system for creating an immersive enhanced reality-driven exercise experience for a user |
US11282608B2 (en) | 2019-10-03 | 2022-03-22 | Rom Technologies, Inc. | Method and system for using artificial intelligence and machine learning to provide recommendations to a healthcare provider in or near real-time during a telemedicine session |
US11325005B2 (en) | 2019-10-03 | 2022-05-10 | Rom Technologies, Inc. | Systems and methods for using machine learning to control an electromechanical device used for prehabilitation, rehabilitation, and/or exercise |
US11915816B2 (en) | 2019-10-03 | 2024-02-27 | Rom Technologies, Inc. | Systems and methods of using artificial intelligence and machine learning in a telemedical environment to predict user disease states |
US12150792B2 (en) | 2019-10-03 | 2024-11-26 | Rom Technologies, Inc. | Augmented reality placement of goniometer or other sensors |
US11265234B2 (en) | 2019-10-03 | 2022-03-01 | Rom Technologies, Inc. | System and method for transmitting data and ordering asynchronous data |
US11515021B2 (en) | 2019-10-03 | 2022-11-29 | Rom Technologies, Inc. | Method and system to analytically optimize telehealth practice-based billing processes and revenue while enabling regulatory compliance |
US11955223B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using artificial intelligence and machine learning to provide an enhanced user interface presenting data pertaining to cardiac health, bariatric health, pulmonary health, and/or cardio-oncologic health for the purpose of performing preventative actions |
US11955221B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using AI/ML to generate treatment plans to stimulate preferred angiogenesis |
US11337648B2 (en) | 2020-05-18 | 2022-05-24 | Rom Technologies, Inc. | Method and system for using artificial intelligence to assign patients to cohorts and dynamically controlling a treatment apparatus based on the assignment during an adaptive telemedical session |
US11955220B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using AI/ML and telemedicine for invasive surgical treatment to determine a cardiac treatment plan that uses an electromechanical machine |
US11075000B2 (en) | 2019-10-03 | 2021-07-27 | Rom Technologies, Inc. | Method and system for using virtual avatars associated with medical professionals during exercise sessions |
US11978559B2 (en) | 2019-10-03 | 2024-05-07 | Rom Technologies, Inc. | Systems and methods for remotely-enabled identification of a user infection |
US11961603B2 (en) | 2019-10-03 | 2024-04-16 | Rom Technologies, Inc. | System and method for using AI ML and telemedicine to perform bariatric rehabilitation via an electromechanical machine |
US12220201B2 (en) | 2019-10-03 | 2025-02-11 | Rom Technologies, Inc. | Remote examination through augmented reality |
US11087865B2 (en) | 2019-10-03 | 2021-08-10 | Rom Technologies, Inc. | System and method for use of treatment device to reduce pain medication dependency |
US12224052B2 (en) | 2019-10-03 | 2025-02-11 | Rom Technologies, Inc. | System and method for using AI, machine learning and telemedicine for long-term care via an electromechanical machine |
US11830601B2 (en) | 2019-10-03 | 2023-11-28 | Rom Technologies, Inc. | System and method for facilitating cardiac rehabilitation among eligible users |
US12154672B2 (en) | 2019-10-03 | 2024-11-26 | Rom Technologies, Inc. | Method and system for implementing dynamic treatment environments based on patient information |
US11317975B2 (en) | 2019-10-03 | 2022-05-03 | Rom Technologies, Inc. | Method and system for treating patients via telemedicine using sensor data from rehabilitation or exercise equipment |
US12087426B2 (en) | 2019-10-03 | 2024-09-10 | Rom Technologies, Inc. | Systems and methods for using AI ML to predict, based on data analytics or big data, an optimal number or range of rehabilitation sessions for a user |
US11887717B2 (en) | 2019-10-03 | 2024-01-30 | Rom Technologies, Inc. | System and method for using AI, machine learning and telemedicine to perform pulmonary rehabilitation via an electromechanical machine |
US12347543B2 (en) | 2019-10-03 | 2025-07-01 | Rom Technologies, Inc. | Systems and methods for using artificial intelligence to implement a cardio protocol via a relay-based system |
US12230382B2 (en) | 2019-10-03 | 2025-02-18 | Rom Technologies, Inc. | Systems and methods for using artificial intelligence and machine learning to predict a probability of an undesired medical event occurring during a treatment plan |
US12100499B2 (en) | 2020-08-06 | 2024-09-24 | Rom Technologies, Inc. | Method and system for using artificial intelligence and machine learning to create optimal treatment plans based on monetary value amount generated and/or patient outcome |
US11101028B2 (en) | 2019-10-03 | 2021-08-24 | Rom Technologies, Inc. | Method and system using artificial intelligence to monitor user characteristics during a telemedicine session |
US20210134412A1 (en) | 2019-10-03 | 2021-05-06 | Rom Technologies, Inc. | System and method for processing medical claims using biometric signatures |
US11756666B2 (en) | 2019-10-03 | 2023-09-12 | Rom Technologies, Inc. | Systems and methods to enable communication detection between devices and performance of a preventative action |
US11826613B2 (en) | 2019-10-21 | 2023-11-28 | Rom Technologies, Inc. | Persuasive motivation for orthopedic treatment |
US20230040185A1 (en) * | 2020-01-10 | 2023-02-09 | Prenosis, Inc. | A time-sensitive trigger for a streaming data environment |
KR20210095375A (en) * | 2020-01-23 | 2021-08-02 | 삼성전자주식회사 | Apparatus and method for estimating bio-information |
KR102605901B1 (en) * | 2020-03-10 | 2023-11-23 | 삼성전자주식회사 | Apparatus and method for estimating bio-information |
US11107591B1 (en) | 2020-04-23 | 2021-08-31 | Rom Technologies, Inc. | Method and system for describing and recommending optimal treatment plans in adaptive telemedical or other contexts |
JP7462300B2 (en) * | 2020-05-08 | 2024-04-05 | 公立大学法人北九州市立大学 | BLOOD PRESSURE MEASURING DEVICE, BLOOD PRESSURE MEASURING SYSTEM, VEHICLE, AND BLOOD PRESSURE MEASURING METHOD |
CN111528825A (en) * | 2020-05-14 | 2020-08-14 | 浙江大学 | Photoelectric volume pulse wave signal optimization method |
JP6916573B1 (en) * | 2020-06-01 | 2021-08-11 | 株式会社Arblet | Information processing systems, servers, information processing methods and programs |
WO2021246346A1 (en) * | 2020-06-01 | 2021-12-09 | 株式会社Arblet | Information processing system, server, information processing method, and program |
CN111685749B (en) * | 2020-06-18 | 2022-09-02 | 郑昕 | Construction method of pulse pressure wave mathematical model |
CN115955937A (en) | 2020-06-26 | 2023-04-11 | 罗姆科技股份有限公司 | Systems, methods, and apparatus for anchoring an electronic device and measuring joint angle |
JP7390990B2 (en) * | 2020-07-17 | 2023-12-04 | 東京エレクトロン株式会社 | Display method and substrate processing equipment |
JP7614584B2 (en) | 2020-08-19 | 2025-01-16 | セコム株式会社 | DETECTION APPARATUS, DETECTION METHOD, AND PROGRAM |
DE102020124582A1 (en) * | 2020-09-22 | 2022-03-24 | Drägerwerk AG & Co. KGaA | Medical device for evaluating a pulsatile signal |
JP2022080166A (en) * | 2020-11-17 | 2022-05-27 | 旭化成メディカル株式会社 | Heart beat information acquisition device and heart beat information acquisition program |
JP2022121340A (en) * | 2021-02-08 | 2022-08-19 | 阿部 真一 | Calculating blood flow rate, blood vessel diameter, blood vessel flow resistance, heart load factor, and the like according to measurement result of blood pressure manometer and displaying them to blood pressure manometer |
CN117015338A (en) * | 2021-03-18 | 2023-11-07 | 泰尔茂株式会社 | Arterial pressure estimation device, arterial pressure estimation system, and arterial pressure estimation method |
CN113555082B (en) * | 2021-07-26 | 2023-06-16 | 无锡市第二人民医院 | Intelligent guiding training method for respiratory function |
JP7615511B2 (en) * | 2021-08-19 | 2025-01-17 | 株式会社村田製作所 | Biometric sensor and biological information measuring system |
JPWO2023048158A1 (en) * | 2021-09-22 | 2023-03-30 | ||
CN113995396B (en) * | 2021-12-24 | 2022-04-15 | 北京乾合晶芯电子技术有限公司 | Be applied to cardiovascular internal medicine's blood pressure monitor |
CN114176533A (en) * | 2021-12-29 | 2022-03-15 | 上海国民集团健康科技有限公司 | Pulse pressure instrument and pulse pressure measurement system based on cunguanchi pulse condition independent measurement and wrist measurement |
CN114297186B (en) * | 2021-12-30 | 2024-04-26 | 广西电网有限责任公司 | Power consumption data preprocessing method and system based on deviation coefficient |
US20250176905A1 (en) * | 2022-03-15 | 2025-06-05 | Livemetric (Medical) S.A. | Devices and methods for predicting effect of a cardiovascular medication administration program |
CN115990001B (en) * | 2023-03-21 | 2024-04-05 | 首都医科大学宣武医院 | Wearable monitoring system, wearable device and storage medium |
CN118717096A (en) * | 2023-07-31 | 2024-10-01 | 华为技术有限公司 | A detection method and wearable device |
CN117958824B (en) * | 2024-03-29 | 2024-06-11 | 大连清东科技有限公司 | Kidney disease personnel state monitoring and analyzing method |
CN118448066B (en) * | 2024-04-29 | 2024-11-29 | 武汉光谷康服信息科技有限公司 | A management system and method for smart health |
CN119366891B (en) * | 2024-12-27 | 2025-03-07 | 广东乐心医疗电子股份有限公司 | Blood pressure measurement method and device based on data processing |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649929A (en) * | 1981-06-11 | 1987-03-17 | Sri International | Method and apparatus for diagnosis of coronary artery disease |
CN1158077A (en) * | 1995-05-12 | 1997-08-27 | 精工爱普生株式会社 | Apparatus for diagnosing condition of living organism and control unit |
JP2000515791A (en) * | 1996-07-31 | 2000-11-28 | メッドウェイブ,インコーポレイテッド | Heart rate start point detector |
JP2002224061A (en) * | 2001-01-31 | 2002-08-13 | Omron Corp | Electronic sphygmomanometer |
JP3595593B2 (en) * | 1995-03-01 | 2004-12-02 | コーリンメディカルテクノロジー株式会社 | Blood ejection function evaluation device |
WO2006079829A1 (en) * | 2005-01-27 | 2006-08-03 | Uws Ventures Limited | Phosphoglycerides for use in improving heart rate recovery and increasing exercise capacity |
JP3921775B2 (en) * | 1998-01-27 | 2007-05-30 | オムロンヘルスケア株式会社 | Blood pressure monitoring device |
CN101296651A (en) * | 2005-10-24 | 2008-10-29 | 皇家飞利浦电子股份有限公司 | System and method for determining the blood pressure of a patient |
CN102216951A (en) * | 2008-11-19 | 2011-10-12 | 欧姆龙健康医疗事业株式会社 | State of health assessment device |
CN103796669A (en) * | 2011-07-18 | 2014-05-14 | 重症监护诊断股份有限公司 | Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy |
CN103892811A (en) * | 2014-01-22 | 2014-07-02 | 柳凌峰 | Ambulatory blood pressure joint detection and analysis system |
CN104091080A (en) * | 2014-07-14 | 2014-10-08 | 中国科学院合肥物质科学研究院 | Intelligent bodybuilding guidance system and closed-loop guidance method thereof |
Family Cites Families (174)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4365636A (en) | 1981-06-19 | 1982-12-28 | Medicon, Inc. | Method of monitoring patient respiration and predicting apnea therefrom |
NL9100150A (en) | 1991-01-29 | 1992-08-17 | Tno | METHOD FOR DETERMINING THE BATTLE VOLUME AND THE HEART MINUTE VOLUME OF THE HUMAN HEART. |
US7081095B2 (en) * | 2001-05-17 | 2006-07-25 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
JP3219325B2 (en) | 1992-11-05 | 2001-10-15 | 日本コーリン株式会社 | Respiratory rate measuring device |
US5836884A (en) | 1993-12-17 | 1998-11-17 | Pulse Metric, Inc. | Method for diagnosing, monitoring and treating hypertension and other cardiac problems |
JP3583494B2 (en) * | 1995-03-01 | 2004-11-04 | コーリンメディカルテクノロジー株式会社 | Blood ejection function evaluation device |
JPH08317912A (en) | 1995-03-23 | 1996-12-03 | Seiko Instr Inc | Pulse meter |
AUPN236595A0 (en) * | 1995-04-11 | 1995-05-11 | Rescare Limited | Monitoring of apneic arousals |
CN1140582A (en) | 1995-07-20 | 1997-01-22 | 阿兹里尔·佩雷尔 | Method for evaluating cardiovascular function |
JP3794409B2 (en) * | 1995-09-13 | 2006-07-05 | セイコーエプソン株式会社 | Health condition management device |
JP3794410B2 (en) | 1995-09-13 | 2006-07-05 | セイコーエプソン株式会社 | Health condition management device |
WO1997016114A1 (en) | 1995-11-01 | 1997-05-09 | Seiko Epson Corporation | Living body condition measuring apparatus |
WO1997022295A1 (en) | 1995-12-18 | 1997-06-26 | Seiko Epson Corporation | Health care device and exercise supporting device |
JPH09220207A (en) | 1996-02-19 | 1997-08-26 | Omron Corp | Blood pressure calculation device |
EP0829226B1 (en) | 1996-03-22 | 2004-10-27 | Seiko Epson Corporation | Exercise quantity measuring device |
EP0841034B1 (en) * | 1996-04-17 | 2003-08-06 | Seiko Epson Corporation | Arrhythmia detector |
DE69730298T2 (en) | 1996-06-12 | 2005-01-13 | Seiko Epson Corp. | KOERPERTEMPERATURMESSVORRICHTUNG |
JP3876889B2 (en) * | 1996-06-12 | 2007-02-07 | セイコーエプソン株式会社 | Body temperature measuring device |
JP4096376B2 (en) | 1996-07-09 | 2008-06-04 | セイコーエプソン株式会社 | Relaxation instruction equipment |
US5772601A (en) | 1996-08-26 | 1998-06-30 | Colin Corporation | Apparatus for evaluating cardiac function of living subject |
EP1057450A3 (en) | 1996-08-28 | 2001-07-04 | Colin Corporation | Apparatus for evaluating cardiac function of living subject |
US6081742A (en) | 1996-09-10 | 2000-06-27 | Seiko Epson Corporation | Organism state measuring device and relaxation instructing device |
US5865755A (en) * | 1996-10-11 | 1999-02-02 | Dxtek, Inc. | Method and apparatus for non-invasive, cuffless, continuous blood pressure determination |
US5980464A (en) | 1996-12-19 | 1999-11-09 | Colin Corporation | Apparatus for evaluating exercise function of person |
JPH10185639A (en) | 1996-12-27 | 1998-07-14 | Tokyo Gas Co Ltd | Flowmeter |
JP3870514B2 (en) * | 1997-10-31 | 2007-01-17 | セイコーエプソン株式会社 | Stroke volume detection device and cardiac function diagnosis device |
US5865756A (en) | 1997-06-06 | 1999-02-02 | Southwest Research Institute | System and method for identifying and correcting abnormal oscillometric pulse waves |
JP3842390B2 (en) | 1997-07-16 | 2006-11-08 | 元治 長谷川 | Blood pressure measurement device and cardiac function analysis device |
EP0947160B1 (en) | 1997-08-26 | 2006-03-01 | Seiko Epson Corporation | Pulse wave diagnosing device |
US6334850B1 (en) | 1997-11-19 | 2002-01-01 | Seiko Epson Corporation | Method of detecting pulse wave, method of detecting artery position, and pulse wave detecting apparatus |
CN1326489C (en) * | 1997-11-20 | 2007-07-18 | 精工爱普生株式会社 | Pulse wave diagnostic apparatus, blood pressure monitor, pulse shape monitor and pharmacologic effect moritor |
JP3820719B2 (en) | 1997-12-24 | 2006-09-13 | セイコーエプソン株式会社 | Biological condition measuring device |
IL128482A (en) | 1999-02-11 | 2003-06-24 | Ultrasis Internat 1993 Ltd | Method and device for continuous analysis of cardiovascular activity of a subject |
DE60134389D1 (en) | 2000-03-02 | 2008-07-24 | Itamar Medical Ltd | METHOD AND DEVICE FOR NON-INVASIVE DETERMINATION OF SLEEPING STATES BY MONITORING THE PERIPHERAL VASCULAR SYSTEM |
US7806831B2 (en) * | 2000-03-02 | 2010-10-05 | Itamar Medical Ltd. | Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system |
US6955648B2 (en) | 2000-09-29 | 2005-10-18 | New Health Sciences, Inc. | Precision brain blood flow assessment remotely in real time using nanotechnology ultrasound |
US6918879B2 (en) | 2000-10-09 | 2005-07-19 | Healthstats International Pte. Ltd. | Method and device for monitoring blood pressure |
SG94349A1 (en) | 2000-10-09 | 2003-02-18 | Healthstats Int Pte Ltd | Method and device for monitoring blood pressure |
JP2002224059A (en) | 2001-01-31 | 2002-08-13 | Omron Corp | Electronic sphygmomanometer |
JP3495344B2 (en) | 2001-05-16 | 2004-02-09 | 日本コーリン株式会社 | Pressure pulse wave detector |
JP4759860B2 (en) | 2001-07-11 | 2011-08-31 | セイコーエプソン株式会社 | Anoxic work threshold detection device |
US6773397B2 (en) | 2001-10-11 | 2004-08-10 | Draeger Medical Systems, Inc. | System for processing signal data representing physiological parameters |
US6730038B2 (en) | 2002-02-05 | 2004-05-04 | Tensys Medical, Inc. | Method and apparatus for non-invasively measuring hemodynamic parameters using parametrics |
US6805673B2 (en) | 2002-02-22 | 2004-10-19 | Datex-Ohmeda, Inc. | Monitoring mayer wave effects based on a photoplethysmographic signal |
TW570769B (en) | 2002-04-26 | 2004-01-11 | Chin-Yu Lin | Method and device for measuring pulse signals for simultaneously obtaining pulse pressure and blood flow rate |
US6869402B2 (en) | 2002-08-27 | 2005-03-22 | Precision Pulsus, Inc. | Method and apparatus for measuring pulsus paradoxus |
DE10243265A1 (en) | 2002-09-17 | 2004-03-25 | Andreas Nuske | Heart condition diagnosis method is based on analysis of bioelectrical signals recorded using a measurement glove that has a pulse sensor and electronics with an evaluation algorithm stored in ROM |
US8672852B2 (en) * | 2002-12-13 | 2014-03-18 | Intercure Ltd. | Apparatus and method for beneficial modification of biorhythmic activity |
US20050096557A1 (en) | 2003-01-08 | 2005-05-05 | Frederick Vosburgh | Noninvasive cardiovascular monitoring methods and devices |
JP4025220B2 (en) | 2003-03-03 | 2007-12-19 | ▲苅▼尾 七臣 | Blood pressure monitor and cardiovascular disease risk analysis program |
US7524292B2 (en) | 2003-04-21 | 2009-04-28 | Medtronic, Inc. | Method and apparatus for detecting respiratory disturbances |
JP4327524B2 (en) | 2003-07-03 | 2009-09-09 | ▲苅▼尾 七臣 | Blood pressure abnormality inspection device at load change |
US7244225B2 (en) | 2003-10-07 | 2007-07-17 | Cardiomedics, Inc. | Devices and methods for non-invasively improving blood circulation |
WO2005069740A2 (en) * | 2004-01-27 | 2005-08-04 | Cardiometer Ltd. | Method and system for cardiovascular system diagnosis |
JP2005237472A (en) | 2004-02-24 | 2005-09-08 | 七臣 ▲苅▼尾 | Sphygmomanometry instrument |
JP3987053B2 (en) | 2004-03-30 | 2007-10-03 | 株式会社東芝 | Sleep state determination device and sleep state determination method |
US7828711B2 (en) | 2004-08-16 | 2010-11-09 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular growth and regeneration using ventricular assist device |
US20060047202A1 (en) | 2004-09-02 | 2006-03-02 | Elliott Stephen B | Method and system of breathing therapy for reducing sympathetic predominance with consequent positive modification of hypertension |
CN1284512C (en) * | 2004-10-21 | 2006-11-15 | 中国人民解放军空军航空医学研究所 | Digital medical information monitoring and control system for full ward |
JP4752259B2 (en) | 2004-12-10 | 2011-08-17 | オムロンヘルスケア株式会社 | Electronic blood pressure monitor and blood pressure measurement system |
JP4342455B2 (en) | 2005-02-03 | 2009-10-14 | 株式会社東芝 | Health management device and health management system |
US20060195035A1 (en) * | 2005-02-28 | 2006-08-31 | Dehchuan Sun | Non-invasive radial artery blood pressure waveform measuring apparatus system and uses thereof |
WO2006100676A2 (en) | 2005-03-21 | 2006-09-28 | Health-Smart Limited | System for continuous blood pressure monitoring |
US8423108B2 (en) | 2005-03-24 | 2013-04-16 | Intelomed, Inc. | Device and system that identifies cardiovascular insufficiency |
DE102005014950A1 (en) * | 2005-04-01 | 2006-10-12 | Braun Gmbh | Method for determining cardiovascular parameters and device and computer program product for carrying out the method |
JP5687741B2 (en) | 2005-04-22 | 2015-03-18 | フクダ電子株式会社 | Biological information output device and method, and biological information report |
WO2006121455A1 (en) | 2005-05-10 | 2006-11-16 | The Salk Institute For Biological Studies | Dynamic signal processing |
CN1723839A (en) | 2005-07-21 | 2006-01-25 | 高春平 | Method and device for testing health-index of individualized and three-D type |
CN1903117A (en) * | 2005-07-27 | 2007-01-31 | 孙德铨 | Non-invasive Radial Artery Blood Pressure Waveform Measurement System and Its Application |
JP2007117591A (en) | 2005-10-31 | 2007-05-17 | Konica Minolta Sensing Inc | Pulse wave analyzer |
EP1785088A1 (en) | 2005-11-14 | 2007-05-16 | Congener Wellness Corp. | A system and method for the management and control of cardiovascular related diseases, such as hypertension |
CN1985750B (en) * | 2005-12-21 | 2011-03-23 | 深圳迈瑞生物医疗电子股份有限公司 | Pulse wave detecting method and device by means of cardiac symbol signal |
JP2007190275A (en) | 2006-01-20 | 2007-08-02 | Omron Healthcare Co Ltd | Breathing exerciser |
US7607243B2 (en) * | 2006-05-03 | 2009-10-27 | Nike, Inc. | Athletic or other performance sensing systems |
JP4901309B2 (en) | 2006-05-31 | 2012-03-21 | 株式会社デンソー | Biological state detection device, control device, and pulse wave sensor mounting device |
JP2008005964A (en) | 2006-06-28 | 2008-01-17 | Omron Healthcare Co Ltd | Apnea controller and program for apnea control |
JP2008061824A (en) | 2006-09-07 | 2008-03-21 | Omron Healthcare Co Ltd | Medical measuring instrument, biosignal waveform extraction method and biosignal waveform extraction program |
US20080064965A1 (en) | 2006-09-08 | 2008-03-13 | Jay Gregory D | Devices and methods for measuring pulsus paradoxus |
CN100466968C (en) | 2006-09-29 | 2009-03-11 | 北京新兴阳升科技有限公司 | Detection method of Korotkoff sound delay and pulse wave transit time blood pressure monitor and signal generator using it |
JP4789203B2 (en) | 2006-10-02 | 2011-10-12 | フクダ電子株式会社 | Blood pressure reflex function measuring device |
US8652040B2 (en) * | 2006-12-19 | 2014-02-18 | Valencell, Inc. | Telemetric apparatus for health and environmental monitoring |
US9044136B2 (en) | 2007-02-16 | 2015-06-02 | Cim Technology Inc. | Wearable mini-size intelligent healthcare system |
US8047998B2 (en) | 2007-04-17 | 2011-11-01 | General Electric Company | Non-invasive blood pressure determination method |
DE102007020038A1 (en) | 2007-04-27 | 2008-10-30 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Evidence of apnea with blood pressure dependent detected signals |
US20080319327A1 (en) | 2007-06-25 | 2008-12-25 | Triage Wireless, Inc. | Body-worn sensor featuring a low-power processor and multi-sensor array for measuring blood pressure |
JP4714194B2 (en) | 2007-08-09 | 2011-06-29 | オムロンヘルスケア株式会社 | Blood pressure measurement device |
US20090124914A1 (en) | 2007-11-08 | 2009-05-14 | Kuo Terry B J | Analysis system and a method for pulse diagnosis in chinese medicine |
US20090156946A1 (en) | 2007-12-13 | 2009-06-18 | Welch Allyn, Inc. | Blood pressure motion sensing |
JP5045514B2 (en) | 2008-03-19 | 2012-10-10 | オムロンヘルスケア株式会社 | Electronic blood pressure monitor |
JP5151690B2 (en) | 2008-05-27 | 2013-02-27 | オムロンヘルスケア株式会社 | Blood pressure information measuring device and index acquisition method |
JP5211910B2 (en) | 2008-07-23 | 2013-06-12 | オムロンヘルスケア株式会社 | Biological information management system and measuring instrument |
JP5336803B2 (en) | 2008-09-26 | 2013-11-06 | 株式会社東芝 | Pulse wave measuring device |
EP2189111A1 (en) | 2008-11-21 | 2010-05-26 | Pulsion Medical Systems AG | Apparatus and method for determining a physiologic parameter |
CN101773387B (en) | 2009-01-08 | 2011-12-14 | 香港中文大学 | Cuffless arterial blood pressure measurement and automatic calibration device based on somatosensory network |
JP2010200901A (en) | 2009-03-02 | 2010-09-16 | Nippon Koden Corp | Biological signal measuring apparatus |
JP5209545B2 (en) * | 2009-03-09 | 2013-06-12 | 株式会社デンソー | Biopsy device, program, and recording medium |
US20100268097A1 (en) | 2009-03-20 | 2010-10-21 | Edwards Lifesciences Corporation | Monitoring Peripheral Decoupling |
US8057400B2 (en) * | 2009-05-12 | 2011-11-15 | Angiologix, Inc. | System and method of measuring changes in arterial volume of a limb segment |
KR101640498B1 (en) | 2009-05-22 | 2016-07-19 | 삼성전자주식회사 | Blood pressure estimating apparatus and method by using variable characteristic ratio |
CN201409913Y (en) | 2009-06-10 | 2010-02-24 | 吕景文 | Individual physical index monitoring system |
US10195377B2 (en) * | 2009-08-13 | 2019-02-05 | Hidetsugu Asanoi | Device for calculating respiratory waveform information and medical instrument using respiratory waveform information |
CN102043893A (en) | 2009-10-13 | 2011-05-04 | 北京大学 | Disease pre-warning method and system |
JP5536582B2 (en) | 2009-10-22 | 2014-07-02 | 日本光電工業株式会社 | Biological parameter display device |
CN102834047A (en) * | 2010-01-29 | 2012-12-19 | 爱德华兹生命科学公司 | Elimination of the effects of irregular cardiac cycles in the determination of cardiovascular parameters |
US8668649B2 (en) * | 2010-02-04 | 2014-03-11 | Siemens Medical Solutions Usa, Inc. | System for cardiac status determination |
EP2364640A1 (en) | 2010-03-11 | 2011-09-14 | BIOTRONIK SE & Co. KG | Monitoring device and method for operating a monitoring device |
JP5504477B2 (en) | 2010-03-16 | 2014-05-28 | 国立大学法人富山大学 | Fingertip pulse wave analyzer and vascular endothelial function evaluation system using the same |
US8834378B2 (en) | 2010-07-30 | 2014-09-16 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiratory effort |
US8315812B2 (en) | 2010-08-12 | 2012-11-20 | Heartflow, Inc. | Method and system for patient-specific modeling of blood flow |
EP2752156B1 (en) * | 2011-01-24 | 2017-09-27 | Act Medical Service Co., Ltd. | Blood vessel pulse-wave measuring system |
JP5605269B2 (en) * | 2011-02-28 | 2014-10-15 | セイコーエプソン株式会社 | Beat detector |
JP5623955B2 (en) | 2011-03-29 | 2014-11-12 | シチズンホールディングス株式会社 | Sphygmomanometer |
EP2524647A1 (en) * | 2011-05-18 | 2012-11-21 | Alain Gilles Muzet | System and method for determining sleep stages of a person |
JP5738673B2 (en) | 2011-05-24 | 2015-06-24 | オムロンヘルスケア株式会社 | Blood pressure measurement device |
JP2013031568A (en) | 2011-08-02 | 2013-02-14 | Tdk Corp | Method and apparatus for monitoring respiration, and sphygmomanometer with respiration monitoring function |
US9770176B2 (en) | 2011-09-16 | 2017-09-26 | Koninklijke Philips N.V. | Device and method for estimating the heart rate during motion |
SG10201906900QA (en) | 2011-09-30 | 2019-09-27 | Somalogic Inc | Cardiovascular risk event prediction and uses thereof |
JP5927843B2 (en) | 2011-10-28 | 2016-06-01 | セイコーエプソン株式会社 | Congestion determination device, pulse wave measurement device, and congestion determination method |
US9049995B2 (en) | 2012-01-12 | 2015-06-09 | Pacesetter, Inc. | System and method for detecting pulmonary congestion based on stroke volume using an implantable medical device |
EP2782496A4 (en) | 2012-01-30 | 2015-08-05 | Duncan Campbell Invest Pty Ltd | Method and apparatus for non-invasive determination of cardiac output |
JP5953878B2 (en) | 2012-03-30 | 2016-07-20 | 富士通株式会社 | State change detection method, program, and apparatus |
US10405791B2 (en) * | 2013-03-15 | 2019-09-10 | Yingchang Yang | Method and continuously wearable noninvasive apparatus for automatically detecting a stroke and other abnormal health conditions |
CN102697506B (en) | 2012-05-29 | 2014-11-26 | 广州乾华生物科技有限公司 | Method and system for monitoring action response condition |
JP5984088B2 (en) | 2012-06-15 | 2016-09-06 | 国立大学法人 東京大学 | Noninvasive continuous blood pressure monitoring method and apparatus |
JP2014014556A (en) | 2012-07-10 | 2014-01-30 | Omron Healthcare Co Ltd | Electronic sphygmomanometer and sphygmomanometry method |
JP6019854B2 (en) | 2012-07-13 | 2016-11-02 | セイコーエプソン株式会社 | Blood pressure measuring device and parameter correction method for central blood pressure estimation |
JP2015013635A (en) * | 2012-12-27 | 2015-01-22 | 株式会社東海理化電機製作所 | Tire position determination system |
EP2759257B1 (en) | 2013-01-25 | 2016-09-14 | UP-MED GmbH | Method, logic unit and system for determining a parameter representative for the patient's volume responsiveness |
JP2014171589A (en) | 2013-03-07 | 2014-09-22 | Seiko Epson Corp | Atrial fibrillation analyzation equipment and program |
CN103126655B (en) | 2013-03-14 | 2014-10-08 | 浙江大学 | Non-binding goal non-contact pulse wave acquisition system and sampling method |
US9345436B2 (en) | 2013-03-14 | 2016-05-24 | HighDim GmbH | Apparatus and methods for computing cardiac output of a living subject |
US9949696B2 (en) | 2013-03-14 | 2018-04-24 | Tensys Medical, Inc. | Apparatus and methods for computing cardiac output of a living subject via applanation tonometry |
CN103230268B (en) | 2013-03-22 | 2016-02-03 | 浙江理工大学 | A kind of human body detection device that can carry out remote monitoring |
US10390761B2 (en) | 2013-04-16 | 2019-08-27 | Kyocera Corporation | Device, device control method and control program, and system |
CN104138253B (en) | 2013-05-11 | 2016-06-15 | 吴健康 | A kind of noinvasive arteriotony method for continuous measuring and equipment |
CN103230267B (en) * | 2013-05-14 | 2015-06-03 | 北京理工大学 | Anti-movement-interference extraction method for pulse rates |
US9314211B2 (en) | 2013-07-31 | 2016-04-19 | Omron Healthcare Co., Ltd. | Blood pressure measurement device having function of determining rest condition of patient |
CN103479343B (en) * | 2013-09-27 | 2015-02-25 | 上海交通大学 | Central aortic pressure detection system and method based on oscillating sphygmomanometer signals |
JP6347097B2 (en) * | 2013-10-07 | 2018-06-27 | セイコーエプソン株式会社 | Portable device and heartbeat arrival time measurement control method |
US20150164351A1 (en) | 2013-10-23 | 2015-06-18 | Quanttus, Inc. | Calculating pulse transit time from chest vibrations |
JP2016538097A (en) * | 2013-10-23 | 2016-12-08 | クアンタス, インコーポレイテッド | Consumer biometric devices |
JP5911840B2 (en) | 2013-11-25 | 2016-04-27 | 株式会社カオテック研究所 | Diagnostic data generation device and diagnostic device |
US20150196209A1 (en) | 2014-01-15 | 2015-07-16 | Microsoft Corporation | Cardiovascular risk factor sensing device |
CN104055496B (en) | 2014-01-15 | 2016-04-20 | 中国航天员科研训练中心 | A kind of method of estimation of the sports load level based on heart source property signal |
CN104808776A (en) * | 2014-01-24 | 2015-07-29 | 北京奇虎科技有限公司 | Device and method for detecting continuous attaching of head-wearing intelligent device on human body |
JP6282887B2 (en) | 2014-02-28 | 2018-02-21 | 国立大学法人広島大学 | Blood pressure measuring device and blood pressure measuring method |
WO2015153569A1 (en) | 2014-03-31 | 2015-10-08 | The Regents Of The University Of Michigan | Miniature piezoelectric cardiovascular monitoring system |
EP3133985B1 (en) * | 2014-04-24 | 2021-02-24 | Ecole Polytechnique Federale de Lausanne (EPFL) | A method and a device for non invasive blood pressure measurement |
WO2015178439A2 (en) | 2014-05-20 | 2015-11-26 | 株式会社Ainy | Device and method for supporting diagnosis of central/obstructive sleep apnea, and computer-readable medium having stored thereon program for supporting diagnosis of central/obstructive sleep apnea |
JP6358865B2 (en) | 2014-06-13 | 2018-07-18 | 株式会社デンソー | Sphygmomanometer |
JP6285897B2 (en) | 2014-07-28 | 2018-02-28 | シナノケンシ株式会社 | Biological information reader |
CN107072594B (en) | 2014-07-28 | 2020-11-06 | S V Siu联合有限责任公司 | Method and apparatus for assessing respiratory distress |
CN105455797B (en) | 2014-08-19 | 2020-01-07 | 南京茂森电子技术有限公司 | Autonomic nerve heart regulation function measuring method and device |
US20170251927A1 (en) * | 2014-08-27 | 2017-09-07 | Nec Corporation | Blood pressure determination device, blood pressure determination method, recording medium for recording blood pressure determination program, and blood pressure measurement device |
CN104188639B (en) | 2014-09-10 | 2017-02-15 | 朱宇东 | Ambulatory blood pressure continuous monitoring and real-time analysis system |
JP6280487B2 (en) | 2014-10-16 | 2018-02-14 | 東京エレクトロン株式会社 | Substrate processing method and substrate processing apparatus |
JP6366463B2 (en) | 2014-10-31 | 2018-08-01 | オムロンヘルスケア株式会社 | Blood pressure measurement device |
CN104352228A (en) * | 2014-11-10 | 2015-02-18 | 小米科技有限责任公司 | Method and device for processing application program |
CN104382569B (en) | 2014-12-08 | 2017-04-12 | 天津工业大学 | Fiber-optic sensing intelligent garment and heart sound parameter processing methods thereof |
CN104665821A (en) | 2015-01-26 | 2015-06-03 | 周常安 | Cardiovascular health monitoring device and method |
CN104665799A (en) | 2015-01-26 | 2015-06-03 | 周常安 | Blood pressure management device and method |
WO2016119656A1 (en) | 2015-01-26 | 2016-08-04 | 周常安 | Cardiovascular health monitoring device and method |
CN204618202U (en) | 2015-03-11 | 2015-09-09 | 佛山职业技术学院 | A kind of intelligent bangle of athlete's status data remote capture |
CN204708829U (en) | 2015-04-24 | 2015-10-21 | 吉林大学 | A kind of wireless breathing, pulse monitoring device |
CN104856661A (en) | 2015-05-11 | 2015-08-26 | 北京航空航天大学 | Wearable continuous blood pressure estimating system and method based on dynamic compensation of diastolic blood pressure |
CN105030195A (en) * | 2015-06-02 | 2015-11-11 | 牛欣 | Three-position and nine-indicator multi-information acquisition and recognition device based on finger feel pressure application and microarray sensing |
CN104958064A (en) | 2015-07-15 | 2015-10-07 | 四川宇峰科技发展有限公司 | Wearable arteriosclerosis detector and pulse wave velocity detecting method |
CN105054918B (en) | 2015-07-28 | 2018-05-22 | 杭州暖芯迦电子科技有限公司 | A kind of blood pressure computational methods and blood pressure instrument based on the pulse reflective wave transmission time |
CN105078474A (en) | 2015-08-21 | 2015-11-25 | 武汉苏酷科技有限公司 | Blood glucose and blood pressure monitoring and control system |
CN204909471U (en) | 2015-09-05 | 2015-12-30 | 于清 | Acquisition and analysis processing apparatus of sports psychology index data |
CN105266828A (en) | 2015-09-05 | 2016-01-27 | 于清 | Sports psychology index data acquisition analysis and processing device |
CN105361858B (en) | 2015-12-10 | 2018-04-03 | 广东小天才科技有限公司 | Blood pressure data processing method and wearable device |
JP6631376B2 (en) | 2016-04-15 | 2020-01-15 | オムロンヘルスケア株式会社 | Pulse wave detecting device, biological information measuring device, control method of pulse wave detecting device, and control program of pulse wave detecting device |
US11076813B2 (en) | 2016-07-22 | 2021-08-03 | Edwards Lifesciences Corporation | Mean arterial pressure (MAP) derived prediction of future hypotension |
-
2017
- 2017-04-14 JP JP2018512087A patent/JP6687263B2/en active Active
- 2017-04-14 EP EP17782516.3A patent/EP3427654A4/en not_active Ceased
- 2017-04-14 US US16/092,076 patent/US20190159723A1/en not_active Abandoned
- 2017-04-14 WO PCT/JP2017/015279 patent/WO2017179698A1/en active Application Filing
- 2017-04-14 CN CN201780022529.5A patent/CN108882868B/en active Active
- 2017-04-14 WO PCT/JP2017/015281 patent/WO2017179700A1/en active Application Filing
- 2017-04-14 JP JP2018512091A patent/JP6721154B2/en active Active
- 2017-04-14 JP JP2018512089A patent/JP6679005B2/en active Active
- 2017-04-14 EP EP17782511.4A patent/EP3427651A4/en not_active Ceased
- 2017-04-14 JP JP2018512093A patent/JP6679051B2/en active Active
- 2017-04-14 CN CN201780022566.6A patent/CN108882871B/en active Active
- 2017-04-14 US US16/092,151 patent/US11363961B2/en active Active
- 2017-04-14 JP JP2018512086A patent/JP6835395B2/en active Active
- 2017-04-14 CN CN201780022781.6A patent/CN108882878B/en active Active
- 2017-04-14 WO PCT/JP2017/015284 patent/WO2017179703A1/en active Application Filing
- 2017-04-14 US US16/092,097 patent/US11617516B2/en active Active
- 2017-04-14 EP EP17782515.5A patent/EP3427653B1/en active Active
- 2017-04-14 JP JP2018512096A patent/JP6659831B2/en active Active
- 2017-04-14 WO PCT/JP2017/015280 patent/WO2017179699A1/en active Application Filing
- 2017-04-14 EP EP17782512.2A patent/EP3440995B1/en active Active
- 2017-04-14 EP EP17782509.8A patent/EP3427655B1/en active Active
- 2017-04-14 EP EP17782510.6A patent/EP3427650B1/en active Active
- 2017-04-14 WO PCT/JP2017/015276 patent/WO2017179695A1/en active Application Filing
- 2017-04-14 CN CN201780022568.5A patent/CN108882873B/en active Active
- 2017-04-14 US US16/092,060 patent/US20190159722A1/en not_active Abandoned
- 2017-04-14 EP EP17782514.8A patent/EP3427652B1/en active Active
- 2017-04-14 US US16/092,126 patent/US20190159682A1/en not_active Abandoned
- 2017-04-14 CN CN201780022527.6A patent/CN108882867B/en active Active
- 2017-04-14 JP JP2018512088A patent/JP6659830B2/en active Active
- 2017-04-14 WO PCT/JP2017/015282 patent/WO2017179701A1/en active Application Filing
- 2017-04-14 CN CN201780022528.0A patent/CN109069035B/en active Active
- 2017-04-14 US US16/092,136 patent/US20190117084A1/en not_active Abandoned
- 2017-04-14 EP EP17782506.4A patent/EP3427648A4/en not_active Ceased
- 2017-04-14 WO PCT/JP2017/015278 patent/WO2017179697A1/en active Application Filing
- 2017-04-14 CN CN201780022536.5A patent/CN108882869B/en active Active
- 2017-04-14 EP EP17782508.0A patent/EP3427649B1/en active Active
- 2017-04-14 CN CN201780022565.1A patent/CN108882870B/en active Active
- 2017-04-14 CN CN201780022567.0A patent/CN108882872B/en active Active
- 2017-04-14 US US16/092,134 patent/US20190090818A1/en not_active Abandoned
- 2017-04-14 US US16/092,167 patent/US20190110700A1/en not_active Abandoned
- 2017-04-14 WO PCT/JP2017/015283 patent/WO2017179702A1/en active Application Filing
- 2017-04-14 US US16/092,159 patent/US11246501B2/en active Active
- 2017-04-14 US US16/092,095 patent/US20190150755A1/en not_active Abandoned
- 2017-04-14 CN CN201780022537.XA patent/CN108882877B/en active Active
- 2017-04-14 EP EP17782513.0A patent/EP3427656B1/en active Active
- 2017-04-14 WO PCT/JP2017/015275 patent/WO2017179694A1/en active Application Filing
- 2017-04-14 JP JP2018512095A patent/JP6721156B2/en active Active
- 2017-04-14 JP JP2018512094A patent/JP6721155B2/en active Active
- 2017-04-14 CN CN201780022530.8A patent/CN109069013B/en active Active
- 2017-04-14 EP EP17782507.2A patent/EP3430989B1/en active Active
- 2017-04-14 JP JP2018512092A patent/JP6679006B2/en active Active
- 2017-04-14 WO PCT/JP2017/015274 patent/WO2017179693A1/en active Application Filing
- 2017-04-14 US US16/092,113 patent/US20190159685A1/en not_active Abandoned
- 2017-04-14 WO PCT/JP2017/015277 patent/WO2017179696A1/en active Application Filing
- 2017-04-14 JP JP2018512090A patent/JP6721153B2/en active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649929A (en) * | 1981-06-11 | 1987-03-17 | Sri International | Method and apparatus for diagnosis of coronary artery disease |
JP3595593B2 (en) * | 1995-03-01 | 2004-12-02 | コーリンメディカルテクノロジー株式会社 | Blood ejection function evaluation device |
CN1158077A (en) * | 1995-05-12 | 1997-08-27 | 精工爱普生株式会社 | Apparatus for diagnosing condition of living organism and control unit |
JP2000515791A (en) * | 1996-07-31 | 2000-11-28 | メッドウェイブ,インコーポレイテッド | Heart rate start point detector |
JP3921775B2 (en) * | 1998-01-27 | 2007-05-30 | オムロンヘルスケア株式会社 | Blood pressure monitoring device |
JP2002224061A (en) * | 2001-01-31 | 2002-08-13 | Omron Corp | Electronic sphygmomanometer |
WO2006079829A1 (en) * | 2005-01-27 | 2006-08-03 | Uws Ventures Limited | Phosphoglycerides for use in improving heart rate recovery and increasing exercise capacity |
CN101296651A (en) * | 2005-10-24 | 2008-10-29 | 皇家飞利浦电子股份有限公司 | System and method for determining the blood pressure of a patient |
CN102216951A (en) * | 2008-11-19 | 2011-10-12 | 欧姆龙健康医疗事业株式会社 | State of health assessment device |
CN103796669A (en) * | 2011-07-18 | 2014-05-14 | 重症监护诊断股份有限公司 | Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy |
CN103892811A (en) * | 2014-01-22 | 2014-07-02 | 柳凌峰 | Ambulatory blood pressure joint detection and analysis system |
CN104091080A (en) * | 2014-07-14 | 2014-10-08 | 中国科学院合肥物质科学研究院 | Intelligent bodybuilding guidance system and closed-loop guidance method thereof |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108882873B (en) | Biological information analysis device, system, and program |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |